British Columbia, Canada |
7372 |
Not applicable | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
Marc J. Ross Avital Perlman Sichenzia Ross Ference LLP 1185 Avenue of the Americas, 31st Floor New York, NY 10036 Tel: (212) 930-9700 |
Brett Hanson Emily Humbert Fox Rothschild LLP 222 South Ninth Street, Suite 2000 Minneapolis, MN 55402 Tel: (612) 607-7000 |
Emerging growth company |
PRELIMINARY PROSPECTUS |
SUBJECT TO COMPLETION |
DATED AUGUST 9, 2022 |
Per Share |
Per Related Nine Warrants |
Total Without Over-Allotment Option |
Total With Over-Allotment Option |
|||||||||||||
Public offering price |
$ |
24.91 |
$ |
0.09 |
$ |
25,000,000 |
$ |
28,750,000 |
||||||||
Underwriting discounts (1) |
$ |
1.9928 |
$ |
0.0072 |
$ |
2,000,000 |
$ |
2,300,000 |
||||||||
Proceeds, before expenses, to us |
$ |
22.9172 |
$ |
0.0828 |
$ |
23,000,000 |
$ |
26,450,000 |
(1) |
See “Underwriting” on page 113 of this prospectus for a description of all underwriting compensation payable in connection with this offering. |
(2) |
The amount of offering proceeds to us presented in this table does not give effect to any exercise of the over-allotment option we have granted to the underwriter as described below. |
1 |
||||
13 |
||||
33 |
||||
34 |
||||
34 |
||||
34 |
||||
35 |
||||
36 |
||||
74 |
||||
86 |
||||
102 |
||||
103 |
||||
103 |
||||
109 |
||||
113 |
||||
113 |
||||
113 |
||||
118 |
||||
118 |
||||
118 |
||||
F-1 |
• | HVAC units and refrigerators in commercial buildings; |
• | control systems, heat exchangers, and compressors at process industry facilities; and |
• | wind turbines generating renewable energy at onshore wind farms. |
• | curbing wasted energy while improving occupant comfort in commercial facilities through AI-powered adaptive control; |
• | maximizing asset availability and production yields of renewable energy sources through continuous performance assessment and predictive maintenance; and |
• | optimizing the uptime and manage the operational risk of industrial process plants, including oil and gas facilities, through continuous AI-powered advisory and assistance to process operators in the field. |
• | not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, |
• | reduced disclosure obligations regarding executive compensation in periodic reports, proxy statements and registration statements, and |
• | exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. |
• | Quorum Requirement |
• | Shareholder Approval Requirements |
• | Depending on the context, the terms “we,” “us,” “our company,” and “our” refer to mCloud Technologies Corp., and its consolidated subsidiaries: |
• | “preferred shares” refer to our Series A Preferred Shares, no par value. |
• | all references to “CAD”, “CAD$” and “Canadian dollar” are to the legal currency of Canada, and all references to “USD,” “$”, “US$” and “U.S. dollars” are to the legal currency of the United States. |
Series A Preferred Shares |
1,000,000 Series A Preferred Shares on a firm commitment basis | |
Offering Price basis |
$25.00 per Series A Preferred Share and Warrant on a combined basis | |
Warrants |
Warrants to purchase up to 9,000,000 Common Shares, which are exercisable on the date of issuance and expire on November 29, 2026, at an exercise price per Common Share equal to $4.75. | |
Over-allotment Option to purchase additional Common Shares from us |
We have granted the underwriters an option to purchase an additional 150,000 Series A Preferred Shares and/or 1,350,000 Warrants to purchase additional Common Shares from us (being up to 15% of the Series A Preferred Shares, and/or up to 15% of the Warrants sold in this offering), in any combination thereof, at the public offering price per Series A Preferred Share and public offering price per Warrant, respectively, less the underwriting discounts and commissions, for 45 days from the date of this prospectus. | |
Number of Series A Preferred Shares issued and outstanding before this offering |
0 | |
Number of Series A Preferred Shares outstanding after this offering |
1,000,000 shares. | |
Number of Common Shares outstanding prior to offering |
16,155,654 shares. |
Liquidation Preference |
The liquidation preference of each Series A Preferred Share is $25.00 per share. Upon liquidation, holders of Series A Preferred Shares will be entitled to receive the liquidation preference with respect to their Series A Preferred Shares plus an amount equal to accumulated but unpaid dividends with respect to such shares. | |
Conversion |
The Series A Preferred Shares will be convertible into common Shares based on a conversion ratio of (i) the $25.00 per share liquidation preference divided by (ii) $2.75. Therefore, each Series A Preferred Share is convertible into nine Common Shares. Upon such a conversion, any declared but unpaid dividends shall be paid to the holder of Series A Preferred Shares in cash. In the event that the conversion would result in the issuance of fractional Common Shares, we will pay the holder the cash value of such fractional shares in lieu of such fractional shares based on a price of $2.75 per Common Share. | |
Dividends |
Subject to the preferential rights, if any, of the holders of any class or series of capital stock of the Company ranking senior to the Series A Preferred Shares as to dividends, the holders of the Series A Preferred Shares will be entitled to receive, when, as and if declared by the Board (or a duly authorized committee of the Board), only out of funds legally available for the payment of dividends, cumulative cash dividends at the annual rate of 9.0% of the $25.00 liquidation preference per year (equivalent to $2.25 per year) until the beginning of the fifth year, at which time the annual rate will increases 4.0% per calendar quarter until it reaches a maximum of 25.0%. Dividends on the Series A Preferred Shares will accumulate and be cumulative from, and including, the date of original issue by us of the Series A Preferred Shares. However, the Company will be entitled to defer the payment of any declared dividends on the Series A Preferred Shares until the occurrence of a liquidation or Board approved Change of Control of the Company. | |
Ranking |
The Series A Preferred Shares will rank, as to dividend rights and rights upon our liquidation, dissolution or winding up: (1) Senior to all classes or series of our common shares and to all other equity securities issued by us other than any equity securities issued with terms specifically providing that those equity securities rank on a parity with the Series A Preferred Shares; (2) Junior to any future equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series A Preferred Shares with respect to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up; and (3) Effectively junior to all our existing and future indebtedness (including indebtedness convertible into our common shares or preferred shares) and to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our existing or future subsidiaries. | |
No Maturity Date |
The Series A Preferred Shares are perpetual and have no maturity date, and we are not required to redeem the Series A Preferred Shares. Accordingly, all Series A Preferred Shares will remain outstanding indefinitely, unless and until they are redeemed or converted in accordance with their terms. | |
Preemptive Rights |
Holders of Series A Preferred Shares will have no preemptive rights. |
Voting Rights |
In any matter in which the Series A Preferred Shares may vote, as described below, each Series A Preferred Share shall be entitled to one vote per $25.00 of liquidation preference; provided that if the Series A Preferred Shares and any other stock ranking on parity to the Series A Preferred Shares as to dividend rights and rights as to the distribution of assets upon the Corporation’s liquidation, dissolution or winding up are entitled to vote together as a single class on any matter, the holders of each will vote in proportion to their respective liquidation preferences. So long as any Series A Preferred Shares remain outstanding, the Company will not, without the consent or the affirmative vote of the holders of at least two-thirds of the outstanding Series A Preferred Shares and each other class or series of preferred stock entitled to vote thereon (voting together as a single class), given in person or by proxy, either in writing without a meeting or by vote at any meeting called by the Company for the purpose:(i) authorize, create or issue, or increase the number of authorized or issued number of shares of, any class or series of capital stock ranking senior to the Series A Preferred Shares with respect to payment of dividends or the distribution of assets upon the liquidation, dissolution or winding up of the Company or reclassify any authorized capital stock of the Company into any such shares, or create, authorize or issue any obligation or security convertible into or evidencing the right to purchase any such shares; or (ii) amend, alter or repeal the provisions of the Articles of Incorporation, as amended, including the terms of the Series A Preferred Shares, whether by merger, consolidation, transfer or conveyance of all or substantially all of the Company’s assets or otherwise, so as to materially and adversely affect the rights, preferences, privileges or voting powers of the Series A Preferred Shares, taken as a whole. If any event described in paragraph (ii) above would materially and adversely affect the rights, preferences, privileges or voting powers of the Series A Preferred Shares, taken as a whole, disproportionately relative to any other class or series of voting preferred stock (as defined below), the affirmative vote of the holders of at least two-thirds of the outstanding shares of the Series A Preferred Shares, voting as a separate class, will also be required. Furthermore, if holders of shares of the Series A Preferred Shares receive the $25.00 per share of the Series A Preferred Shares liquidation preference plus all declared and unpaid dividends thereon or greater amounts pursuant to the occurrence of any of the events described in paragraph (ii) above, then such holders shall not have any voting rights with respect to the events described in such paragraph. As used herein, “voting preferred stock” means any other class or series of the Company’s preferred stock ranking equally with the Series A Preferred Shares as to dividends (whether cumulative or non-cumulative) and the distribution of the Company’s assets upon liquidation, dissolution or winding up and upon which like voting rights to the Series A Preferred Shares have been conferred and are exercisable. | |
Use of Proceeds |
We intend to use the proceeds from this offering for working capital and general corporate purposes, including retiring convertible debenture debt that was due June 30, 2022. See “Use of Proceeds” for more information. |
Restrictions on Dividends, Redemption and Repurchases |
So long as any Series A Preferred Share remains outstanding, unless we also have either paid or declared and set apart for payment full cumulative dividends on the Series A Preferred Shares for all past completed dividend periods, we will not during any dividend period: (1) pay or declare and set apart for payment any dividends or declare or make any distribution of cash or other property on Common Shares or other capital stock that ranks junior to or on parity with the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up (other than, in each case, (a) a dividend paid in Common Shares or other stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up or (b) any declaration of a Common Share dividend in connection with any stockholders’ rights plan, or the issuance of rights, stock or other property under any stockholders’ rights plan, or the redemption or repurchase of rights pursuant to such plan); (2) redeem, purchase or otherwise acquire Common Shares or other capital stock that ranks junior to or on parity with the Series A Preferred Shares (other than the Series A Preferred Shares) with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up (other than (a) by conversion into or exchange for Common Shares or other capital stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, (b) the redemption of shares of capital stock pursuant to the provisions of our memorandum of articles, as amended, relating to the restrictions upon ownership and transfer of our capital stock, (c) a purchase or exchange offer made on the same terms to holders of all outstanding A Preferred Shares and any other capital stock that ranks on parity with the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, (d) purchases, redemptions or other acquisitions of shares of our capital stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up pursuant to any employment contract, dividend reinvestment and stock purchase plan, benefit plan or other similar arrangement with or for the benefit of employees, officers, directors, consultants or advisors, (e) through the use of the proceeds of a substantially contemporaneous sale of stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, or (f) purchases or other acquisitions of shares of our capital stock pursuant to a contractually binding stock repurchase plan existing prior to the preceding Dividend Payment Date on which dividends were not paid in full); or (3) redeem, purchase or otherwise acquire Series A Preferred Shares (other than (a) by conversion into or exchange for Common Shares or other capital stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, (b) a purchase or exchange offer made on the same terms to holders of all outstanding Series A Preferred Shares or (c) with respect to redemptions, a redemption pursuant to which all Series A Preferred Shares are redeemed). |
Optional Redemption |
The Series A Preferred Shares are not redeemable prior to [ ], which is the first anniversary of the closing date of this offering, except for the circumstances described under “Special Optional Redemption.” On or after [ ], the Series A Preferred Shares may be redeemed at our option, in whole or in part, from time to time, at a redemption price of $25.00 per Series A Preferred Share, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Shares up to, but not including, the date of such redemption, upon the giving of notice. | |
Special Optional Redemption |
Upon the occurrence of any Delisting Event, Change of Control, or $8 VWAP Event, whether before or after [ ], we may, at our option, redeem the Series A Preferred Stock, in whole or in part and within 90 days after the date of the Delisting Event, Change of Control or $8 VWAP Event, by paying $25.00 per share of Series A Preferred Stock, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Stock up to, but not including, the date of such redemption. | |
A “Delisting Event” occurs when, after the original issuance of Series A Preferred Stock, both (i) the shares of Series A Preferred Stock are no longer listed on Nasdaq, the New York Stock Exchange (the “NYSE”) or the NYSE American LLC (“NYSE AMER”), or listed or quoted on an exchange or quotation system that is a successor to Nasdaq, the NYSE or the NYSE AMER, and (ii) the Company not subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), but any Series A Preferred Stock is still outstanding. | ||
A “Change of Control” occurs when, after the original issuance of the Series A Preferred Stock, the following have occurred and are continuing: (a) any person or persons acting together which would constitute a “group” for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), (other than the Company or any subsidiary of the Company) shall beneficially own (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, at least 25% of the total voting power of all classes of capital stock of the Company entitled to vote generally in the election of the Board; (b) Current Directors (as herein defined) shall cease for any reason to constitute at least a majority of the members of the Board (for this purpose, a “Current Director” shall mean any member of the Board as of the date hereof and any successor of a Current Director whose election, or nomination for election by the Company’s shareholders, was approved by at least a majority of the Current Directors then on the Board); (c) (i) the complete liquidation of the Company or (ii) the merger or consolidation of the Company, other than a merger or consolidation in which (x) the holders of the common stock of the Company immediately prior to the consolidation or merger have, directly or indirectly, at least a majority of the common stock of the continuing or surviving corporation immediately after such consolidation or merger or (y) the Board immediately prior to the merger or consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of the continuing or surviving corporation, which liquidation, merger or consolidation has been approved by the shareholders of the Company; or (d) the sale or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of the Company pursuant to an agreement (or agreements) which has (have) been approved by the shareholders of the Company. |
An “$8 VWAP Event” occurs when, after the original issuance of Series A Preferred Stock, the volume weighted average price of the Common Shares on the Nasdaq Capital Market for five consecutive trading days (as reported by Bloomberg L.P. based on a trading day from 9:30 a.m. to 4:02 p.m. (New York City time)) is at least $8.00. | ||
Redemption Upon Request of Holder in Connection with Change of Control: |
Upon the occurrence of a Board Approved Change of Control, holders of our Series A Preferred Shares may (i) require us to redeem their shares of our Series A Preferred Shares at a per share redemption price of $25.00, plus declared and unpaid dividends to, but excluding, the effective date of the Change of Control, or (ii) continue to hold our Series A Preferred Shares (subject to the Company’s option to redeem the Series A Preferred Shares as set forth above). | |
Segregated Dividend Payment Account |
The Company shall establish a segregated account that will be funded at closing of the offering with proceeds in an amount equal to nine (9) months of dividends on the maximum number of Series A Preferred Shares. The segregated account may only be used to pay dividends declared on the Series A Preferred Shares, when legally permitted, and may not be used for other corporate purposes. | |
Listing |
We are in the process of applying to have the Series A Preferred Shares listed on Nasdaq under the symbol “MCLDP.” There is no assurance that our listing application will be approved. Our Warrants will trade on the Nasdaq along with the Listed Warrants under the symbol “MCLDW.” Our Common Shares are listed on Nasdaq under the symbol “MCLD” and our Listed Warrants are listed under the symbol “MCLDW.” Our Common Shares are also listed on the TSXV under the symbol “MCLD”. | |
Risk Factors |
Investing in these securities involves a high degree of risk. |
Year ended December 31, |
||||||||||||||||
Three months ended March 31, 2022 |
2021 |
2020 |
2019 |
|||||||||||||
Revenue |
$ | 4,429,603 | $ | 25,596,972 | $ | 26,928,439 | $ | 18,340,249 | ||||||||
Cost of sales |
(1,932,356 | ) | (9,683,748 | ) | (10,281,922 | ) | (7,583,127 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
$ | 2,497,247 | $ | 15,913,224 | $ | 16,646,517 | $ | 10,757,122 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Expenses |
||||||||||||||||
Salaries, wages and benefits |
5,314,330 | 21,691,774 | 20,885,044 | 10,313,803 | ||||||||||||
Sales and marketing |
762,231 | 1,377,255 | 1,536,420 | 3,166,788 | ||||||||||||
Research and development |
531,950 | 3,179,353 | 1,078,164 | 498,099 | ||||||||||||
General and administration |
2,552,013 | 8,538,854 | 5,741,872 | 3,294,550 | ||||||||||||
Professional and consulting fees |
3,176,043 | 9,085,436 | 8,886,341 | 4,351,812 | ||||||||||||
Share-based compensation |
252,933 | 1,867,915 | 1,454,235 | 1,468,361 | ||||||||||||
Depreciation and amortization |
1,943,213 | 8,924,812 | 6,778,100 | 4,044,143 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
$ | 14,532,713 | $ | 54,665,399 | $ | 46,360,176 | $ | 27,137,556 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
$ | 12,035,466 | $ | 38,752,175 | $ | 29,713,659 | $ | 16,380,434 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other expenses (income) |
||||||||||||||||
Finance costs |
1,858,637 | 8,618,794 | 6,033,510 | 3,217,500 | ||||||||||||
Foreign exchange loss (gain) |
622,509 | (267,294 | ) | 1,198,372 | 494,404 | |||||||||||
Business acquisition costs and other expenses |
— | 346,420 | 1,811,682 | 9,880,170 | ||||||||||||
Impairment |
— | — | — | 600,657 | ||||||||||||
Fair value loss on derivatives |
(2,493,270 | ) | 6,040,121 | — | — | |||||||||||
Other income |
(398,268 | ) | (7,126,097 | ) | (2,932,342 | ) | (167,913 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before tax |
$ | 11,625,074 | $ | 46,364,119 | $ | 35,824,881 | $ | 30,405,252 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Current tax expense (recovery) |
288,863 | 157,303 | (295,709 | ) | 181,895 | |||||||||||
Deferred tax (recovery) expense |
(890,816 | ) | (1,822,109 | ) | (668,209 | ) | (2,692,313 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss for the year |
11,023,121 |
$ |
44,699,313 |
$ |
34,860,963 |
$ |
27,894,834 |
|||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive (income) loss |
||||||||||||||||
Foreign subsidiary translation differences |
(649,089 | ) | 69,460 | (1,209,006 | ) | (607,302 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive loss for the year |
$ |
10,374,032 |
$ |
44,768,773 |
$ |
33,651,957 |
$ |
27,287,532 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
9,777,570 | 44,329,707 | 36,870,267 | 29,839,342 | ||||||||||||
Non-controlling interest |
1,245,551 | 369,606 | (2,009,304 | ) | (1,944,508 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$11,023,121 |
$44,699,313 |
$ 34,860,963 |
$27,894,834 |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
9,147,568 | 44,427,305 | 35,563,921 | 29,431,628 | ||||||||||||
Non-controlling interest |
1,226,464 | 341,468 | (1,911,964 | ) | (2,144,096 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$10,374,032 |
$44,768,773 |
$ 33,651,957 |
$27,287,532 |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss per share attributable to mCloud shareholders – basic and diluted |
$ |
0.61 |
$ |
3.73 |
$ |
5.07 |
$ |
7.30 |
||||||||
Weighted average number of common shares outstanding basic and diluted |
16,147,560 |
11,898,183 |
7,272,464 |
4,085,322 |
||||||||||||
|
|
|
|
|
|
|
|
March 31, 2022 |
December 31, 2021 |
December 31, 2020 |
December 31, 2019 |
|||||||||||||
ASSETS |
||||||||||||||||
Current assets |
||||||||||||||||
Cash and cash equivalents |
$ | 1,873,021 | $ | 4,588,057 | $ | 1,110,889 | 529,190 | |||||||||
Trade and other receivables |
13,736,106 | 14,566,975 | 12,312,814 | 9,091,654 | ||||||||||||
Current portion of prepaid expenses and other assets |
2,287,443 | 2,355,350 | 1,326,319 | 839,012 | ||||||||||||
Current portion of long-term receivables |
471,909 | 397,060 | 445,213 | 378,221 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current assets |
$ | 18,368,479 | $ | 21,907,442 | $ | 15,195,235 | $ | 10,838,077 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-current assets |
||||||||||||||||
Prepaid expenses and other assets |
165,698 | 622,577 | 1,011,847 | 86,913 | ||||||||||||
Long-term receivables |
992,732 | 343,371 | 2,091,059 | 1,586,429 | ||||||||||||
Right-of-use |
7,033,377 | 916,028 | 3,660,717 | 4,206,808 | ||||||||||||
Property and equipment |
564,253 | 649,403 | 506,387 | 710,552 | ||||||||||||
Intangible assets |
18,923,489 | 20,585,833 | 27,766,839 | 23,671,089 | ||||||||||||
Goodwill |
27,042,823 | 27,081,795 | 27,086,727 | 18,758,975 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total non-current assets |
54,722,372 | $ | 50,199,007 | $ | 62,123,576 | 49,020,766 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
73,090,851 |
$ |
72,106,449 |
$ |
77,318,811 |
59,858,843 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
LIABILITIES |
||||||||||||||||
Current liabilities |
||||||||||||||||
Bank indebtedness |
4,710,549 | $ | 3,460,109 | $ | 976,779 | 1,471,805 | ||||||||||
Trade payables and accrued liabilities |
17,079,919 | 12,421,309 | 12,924,256 | 9,636,405 | ||||||||||||
Deferred revenue |
4,694,450 | 2,811,408 | 1,771,120 | 1,138,281 | ||||||||||||
Current portion of loans and borrowings |
12,480,038 | 12,447,939 | 3,431,251 | 3,004,717 | ||||||||||||
Current portion of convertible debentures |
22,922,383 | 22,185,170 | — | — | ||||||||||||
Warrant liabilities |
6,060,782 | 8,880,038 | 710,924 | 725,086 | ||||||||||||
Current portion of lease liabilities |
453,855 | 410,674 | 835,472 | 720,457 | ||||||||||||
Current portion of other liabilities |
— | — | 6,003,838 | |||||||||||||
Current portion of business acquisition payable |
1,389,094 | 1,398,972 | 1,594,297 | 1,043,314 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current liabilities |
69,791,070 | $ | 64,015,619 | $ | 28,247,937 | 17,740,065 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-current liabilities |
||||||||||||||||
Convertible debentures |
111,411 | 110,540 | 19,534,988 | 17,535,946 | ||||||||||||
Lease liabilities |
6,773,990 | 634,798 | 3,109,604 | 3,641,627 | ||||||||||||
Loans and borrowings |
646,137 | 767,662 | 9,721,049 | 10,968,338 | ||||||||||||
Deferred income tax liabilities |
1,407,503 | 2,291,057 | 4,168,905 | 3,854,614 | ||||||||||||
Other liabilities |
— | — | 232,577 | |||||||||||||
Business acquisition payable |
— | — | 845,232 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
78,730,111 |
$ |
67,819,676 |
$ |
65,860,292 |
53,740,590 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
EQUITY |
||||||||||||||||
Share capital |
118,275,850 | 118,195,363 | 83,120,611 | 45,368,745 | ||||||||||||
Contributed surplus |
11,408,263 | 11,040,751 | 8,518,476 | 7,278,119 | ||||||||||||
Accumulative other comprehensive income |
2,202,000 | 1,571,998 | 1,669,596 | 363,250 | ||||||||||||
Deficit |
(139,793,643 | ) | (130,016,073 | ) | (85,686,366 | ) | (48,816,099 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total shareholders’ equity |
(7,907,530 | ) | $ | 792,039 | $ | 7,622,317 | 4,194,015 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-controlling interest |
2,268,270 | 3,494,734 | 3,836,202 | 1,924,238 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total equity |
$ |
(5,639,260 |
) |
$ |
4,286,773 |
$ |
11,458,519 |
6,118,253 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities and equity |
$ |
73,090,851 |
$ |
72,106,449 |
$ |
77,318,811 |
59,858,843 |
|||||||||
|
|
|
|
|
|
|
|
• | As a company primarily based outside of the United States, our business is subject to economic, political, regulatory and other risks associated with international operations. |
• | mCloud may be unable to identify and complete suitable platform acquisitions and acquisitions in its existing vertical markets. |
• | Potential acquisitions could be difficult to consummate and integrate into mCloud’s operations, and they and investment transactions could disrupt mCloud’s business, dilute stockholder value or impair mCloud’s financial results. |
• | The loss of one or more of mCloud’s key personnel, or its failure to attract and retain other highly qualified personnel in the future, could harm its business. |
• | We may acquire contingent liabilities through acquisitions that could adversely affect mCloud’s operating results. |
• | Acquisitions, investments, joint ventures and other business ventures may negatively affect mCloud’s operating results. |
• | We may not be able to protect our intellectual property rights, which could make us less competitive and cause us to lose market share. The loss of our rights to use technology currently licensed by third parties could increase operating expenses by forcing us to seek alternative technology and adversely affect our ability to compete. |
• | If mCloud is not able to maintain and enhance the AssetCare brand, or if events occur that damage the AssetCare reputation and brand, mCloud’s ability to expand its base of users may be impaired, which could adversely affect mCloud’s business and financial results. |
• | Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada. |
• | failure to realize anticipated returns on investment, cost savings and synergies; |
• | difficulty in assimilating the operations, policies, and personnel of the acquired company; |
• | unanticipated costs associated with acquisitions; |
• | challenges in combining product offerings and entering into new markets in which we may not have experience; |
• | distraction of management’s attention from normal business operations; |
• | potential loss of key employees of the acquired company; |
• | difficulty implementing effective internal controls over financial reporting and disclosure controls and procedures; |
• | impairment of relationships with customers or suppliers; |
• | possibility of incurring impairment losses related to goodwill and intangible assets; and |
• | other issues not discovered in due diligence, which may include product quality issues or legal or other contingencies. |
• | the usefulness, ease of use, performance, and reliability of mCloud’s products compared to its competitors; |
• | the size and composition of mCloud’s user base; |
• | the engagement of mCloud’s users with its products; |
• | the timing and market acceptance of mCloud’s products, including developments and enhancements, or similar improvements by its competitors; |
• | mCloud’s ability to monetize its products, including its ability to successfully monetize AssetCare; |
• | customer service and support efforts; |
• | marketing and selling efforts; |
• | mCloud’s financial condition and results of operations; |
• | changes mandated by legislation, regulatory authorities, or litigation, including settlements and consent decrees, some of which may have a disproportionate effect on mCloud; |
• | acquisitions or consolidation within mCloud’s industry, which may result in more formidable competitors; |
• | mCloud’s ability to attract, retain, and motivate talented employees, particularly computer engineers; |
• | mCloud’s ability to cost-effectively manage and grow its operations; and |
• | the mCloud reputation and brand strength relative to competitors. |
• | actual or anticipated quarterly fluctuations in its financial results and financial condition; |
• | changes in financial estimates or publication of research reports and recommendations by financial analysts with respect to it or other financial institutions; |
• | reports in the press or investment community generally or relating to mCloud’s reputation or the industry in which it operates; |
• | strategic actions by mCloud or its competitors, such as acquisitions, restructurings, dispositions, or financings; |
• | fluctuations in the stock price and financial results of mCloud’s competitors; |
• | future sales of mCloud’s equity or equity-related securities; |
• | proposed or adopted regulatory changes or developments; |
• | domestic and international economic factors unrelated to mCloud’s performance; and |
• | general market conditions and, in particular, developments related to market conditions for the remote asset management industry. |
• | the timing of the development of future services, |
• | projections of revenue, earnings, capital structure and other financial items, |
• | statements regarding the capabilities of our business operations, |
• | statements of expected future economic performance, |
• | statements regarding competition in our market, and |
• | assumptions underlying statements regarding us or our business. |
Year Ended |
Period End |
|||
December 31, 2019 |
$ | 1.2988 | ||
December 31, 2020 |
$ | 1.2732 | ||
December 31, 2021 |
$ | 1.2678 | ||
March 31, 2022 |
$ | 1.2482 |
• | On an actual basis, as determined in accordance with IFRS; and |
• | On an as adjusted basis to reflect the issuance and sale by us of 1,000,000 Series A Preferred Shares and warrants to purchase up to 9,000,000 Common Shares at an assumed combined public offering price of $25.00 per Series A Preferred Share and related Warrants, assuming no exercise of the Warrants and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. |
As of March 31, 2022 |
||||||||||||
Actual | Pro forma Adjustments |
Pro Forma As Adjusted |
||||||||||
Cash and Cash Equivalents |
$ | 1,873,021 | 5,000,525 | (1) |
$ | 6,873,546 | ||||||
Current portion of loans and borrowings |
12,480,038 | |
— |
|
12,480,038 | |||||||
Current portion of convertible debentures |
22,922,383 | |
(22,922,383 |
) |
— | |||||||
Warrant Liabilities |
6,060,782 | — | (2) |
6,060,782 | ||||||||
Long term convertible debentures |
111,411 | — | 111,411 | |||||||||
Loans and borrowings |
646,137 | — | 646,137 | |||||||||
Equity |
||||||||||||
Common shares, no par value; unlimited number of shares authorized, shares issued and outstanding, actual; unlimited number of shares authorized, 16,151,500 shares issued and outstanding, 9.0% Series A Cumulative Perpetual Preferred Shares of the Company, without par value; 1,000,000 shares issued and outstanding (3) |
||||||||||||
Equity Share Capital |
$ | 118,275,850 | 28,740,800 | (2) |
147,016,650 | |||||||
Contributed Surplus |
$ | 11,408,263 | — | 11,408,263 | ||||||||
Accumulated Other Comprehensive Income |
$ | 2,202,000 | — | 2,202,000 | ||||||||
Deficit |
$ | (139,793,643 | ) | (535,117 | ) | (140,328,760 | ) | |||||
Total Shareholders Deficit |
$ | (7,907,530 | ) | $ | 28,205,683 | $ | 20,298,153 | |||||
Total Deficit |
$ | (5,639,260 | ) | $ | 28,205,683 | $ | 22,566,423 | |||||
(1) | The pro forma adjustment to Cash and Cash Equivalents reflects the increase in cash after payment of the principal value of the convertible debenture and the related accrued interest at March 31, 2022. |
(2) | The amount to be attributed to the warrants has not yet been determined, and has been included in the amount attributed to Equity Share Capital. Upon issuance of the Series A Preferred Shares and Warrants, the total net proceeds will be allocated to Equity Share Capital and Warrant Liabilities. |
(3) | Assumes adoption of the Rights and Restrictions for 9.0% Cumulative Series A Preferred Shares, which was adopted subsequent to March 31, 2022. |
The above discussion and table is based on 16,150,100 Common Shares outstanding as of March 31, 2022, and do not include, as of that date: |
• | 1,136,141 Common Shares issuable upon exercise of Listed Warrants; |
• | 7,529,274 Common Shares issuable upon exercise of Non-Listed Warrants; |
• | 806,734 Common Shares issuable upon exercise of Options |
• | 213,293 Common Shares issuable upon exercise of Restricted Share Units; |
• | 1,579,583 Common Shares issuable upon exercise of Convertible Debt; and |
• | An ineffective control environment resulting from an insufficient number of trained financial reporting and accounting, information technology (IT) and operational personnel with the appropriate skills and knowledge and with assigned responsibility and accountability related to the design, implementation and operating effectiveness of internal control over financial reporting. |
• | The insufficient number of personnel described above contributed to an ineffective risk assessment process necessary to identify all relevant risks of material misstatement and to evaluate the implications of relevant risks on its internal control over financial reporting. |
• | An ineffective information and communication process resulting from (i) insufficient communication of internal control information, including objectives and responsibilities, such as delegation of authority; and (ii) ineffective general IT controls and ineffective controls related to spreadsheets, resulting in insufficient controls to ensure the relevance, timeliness and quality of information used in control activities. |
• | As a consequence of the above and as a result of inadequate segregation of duties and secondary review, the Company had ineffective control activities related to the design, implementation and operating effectiveness of process level and financial reporting controls which had a pervasive impact on the Company’s internal control over financial reporting. |
• | An ineffective monitoring process resulting from the evaluation and communication of internal control deficiencies, including monitoring corrective actions, not being performed in a timely manner. |
• | Identifying key positions necessary to support the Company’s initiatives related to internal controls over financial reporting, and expanding its hiring efforts accordingly. |
• | Hiring consultants to assist with process improvements and control remediation efforts in targeted accounting, IT and operations processes. |
• | Formalizing its entity-wide risk assessment process, and documenting internal ownership of risk monitoring and mitigation efforts, with improved risk monitoring activities and regular reporting to those charged with governance at an appropriate frequency. |
• | Finalize a delegation of authority matrix to enforce desired limits of authority for key transactions, events, and commitments, and communicating these limits of authority to relevant personnel throughout the Company. |
• | Further simplify and streamline its spreadsheet models to reduce the risk of errors in mathematical formulas and improve the ability to verify the logic of spreadsheets. |
• | Hiring a consultant to assist management with process improvements and control remediation for general IT controls. |
• | Continuing to perform scoping exercises and planning for an ERP implementation to streamline the number of applications used for financial reporting activities. |
Years ended December 31 |
2021 |
2020 |
2019 |
|||||||||
Revenues |
$ | 25.597 | $ | 26.928 | $ | 18.340 | ||||||
Gross profit |
15.913 | 16.647 | $ | 10.757 | ||||||||
Total expenses |
54.665 | 46.360 | $ | 27.138 | ||||||||
Other expenses (income) |
5.947 | 5.148 | $ | 11.514 | ||||||||
Net loss |
44.699 | 34.861 | $ | 27.895 | ||||||||
Loss per share attributable to mCloud shareholders – basic and diluted |
3.73 | $ | 5.07 | $ | 2.43 | |||||||
Total assets |
72.106 | $ | 77.319 | $ | 59.859 | |||||||
Total non-current financial liabilities |
1.513 | $ | 33.443 | $ | 32.146 |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 Change % |
2020 vs 2019 Change $ |
2020 vs 2019 Change % |
||||||||||||||||||||||
Revenue |
$ | 25.597 | $ | 26.928 | $ | 18.340 | $ | (1.331 | ) | (5 | )% | $ | 8.588 | 47 | % | |||||||||||||
Cost of Sales |
(9.684 | ) | (10.282 | ) | (7.583 | ) | 0.598 | (6 | )% | (2.699 | ) | 36 | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Gross Profit |
$ |
15.913 |
$ |
16.647 |
$ |
10.757 |
$ |
(0.733 |
) |
(4 |
) % |
$ |
5.890 |
55 |
% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Expenses |
||||||||||||||||||||||||||||
Salaries, wages and benefits |
$ | 21.692 | $ | 20.885 | $ | 10.314 | $ | 0.807 | 4 | % | $ | 10.571 | 102 | % | ||||||||||||||
Sales and marketing |
1.377 | 1.536 | 3.167 | (0.159 | ) | (10 | )% | (1.631 | ) | (51 | )% | |||||||||||||||||
Research and development |
3.179 | 1.078 | 0.498 | 2.101 | 195 | % | 0.580 | 116 | % | |||||||||||||||||||
General and administrative |
8.539 | 5.742 | 3.295 | 2.797 | 49 | % | 2.447 | 74 | % | |||||||||||||||||||
Professional and consulting fees |
9.085 | 8.886 | 4.352 | 0.199 | 2 | % | 4.534 | 104 | % | |||||||||||||||||||
Share-based compensation |
1.868 | 1.454 | 1.468 | 0.414 | 28 | % | (0.014 | ) | (1 | )% | ||||||||||||||||||
Depreciation and amortization |
8.925 | 6.778 | 4.044 | 2.147 | 32 | % | 2.734 | 68 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total expenses |
$ | 54.665 | $ | 46.360 | $ | 27.138 | $ | 8.305 | 18 | % | $ | 19.222 | 71 | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating loss |
$ |
38.752 |
$ |
29.714 |
$ |
16.380 |
$ |
9.039 |
30 |
% |
$ |
13.334 |
81 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other Expenses (income) |
||||||||||||||||||||||||||||
Finance costs |
$ | 8.619 | $ | 6.034 | $ | 3.218 | $ | 2.585 | 43 | % | $ | 2.816 | 88 | % | ||||||||||||||
Foreign exchange loss (gain) |
(0.267 | ) | 1.198 | 0.494 | (1.466 | ) | (122 | )% | 0.704 | 143 | % | |||||||||||||||||
Impairment |
— | — | 0.601 | (0.601 | ) | (100 | )% | |||||||||||||||||||||
Business acquisition costs and other expenses |
0.346 | 1.812 | 9.880 | (1.465 | ) | (81 | )% | (8.068 | ) | (82 | )% | |||||||||||||||||
Fair value loss on derivatives |
6.040 | — | — | 6.040 | 100 | % | — | — | % | |||||||||||||||||||
Other income |
(7.126 | ) | (2.932 | ) | (0.168 | ) | (4.194 | ) | 143 | % | (2.764 | ) | 1645 | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Loss before tax |
$ |
46.364 |
$ |
35.825 |
$ |
30.405 |
$ |
10.539 |
29 |
% |
$ |
5.420 |
18 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Current tax expense (recovery) |
$ | 0.157 | $ | (0.296 | ) | $ | (0.182 | ) | $ | 0.453 | (153 | )% | $ | (0.114 | ) | 63 | % | |||||||||||
Deferred tax (recovery) expense |
(1.822 | ) | (0.668 | ) | 2.692 | (1.154 | ) | 173 | % | (3.360 | ) | (125 | )% | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss for the period |
$ |
44.699 |
$ |
34.861 |
$ |
27.895 |
$ |
9.838 |
28 |
% |
$ |
6.966 |
25 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Major Service Line |
2021 |
2020 |
2019 |
2021 vs 2020 Chabrnge $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
AssetCare Initialization |
$ | 1.250 | $ | 7.689 | $ | 5.965 | $ | (6.439 | ) | (84 | )% | $ | 1.724 | 29 | % | |||||||||||||
AssetCare Over Time |
23.462 | 12.809 | 2.940 | 10.653 | 83 | % | 9.869 | 336 | % | |||||||||||||||||||
Engineering Services |
0.885 | 6.430 | 9.436 | (5.545 | ) | (86 | )% | (3.005 | ) | (32 | )% | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
25.597 |
$ |
26.928 |
$ |
18.340 |
$ |
(1.331 |
) |
(5 |
)% |
$ |
8.588 |
47 |
% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timing of revenue recognition |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Revenue recognized over time |
$ | 24.423 | $ | 18.551 | $ | 12.375 | $ | 5.872 | 32 | % | $ | 6.176 | 50 | % | ||||||||||||||
Revenue recognized at point in time upon completion |
1.174 | 8.377 | 5.965 | (7.202 | ) | (86 | )% | 2.412 | 40 | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
25.597 |
$ |
26.928 |
$ |
18.340 |
$ |
(1.331 |
) |
(5 |
)% |
$ |
8.588 |
47 |
% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, | ||||||||||||
2021 |
2020 |
2019 |
||||||||||
Canada |
$ | 10.734 | $ | 13.833 | $ | 10.890 | ||||||
United States |
6.564 | 5.691 | 7.451 | |||||||||
Japan |
5.850 | 6.447 | — | |||||||||
Australia |
0.994 | 0.152 | — | |||||||||
Other |
1.455 | 0.805 | — | |||||||||
|
|
|
|
|
|
|||||||
Total revenue |
$ |
25.597 |
$ |
26.928 |
$ |
18.341 |
||||||
|
|
|
|
|
|
2021 |
2020 |
2019 |
||||||||||
Customer A |
Less than 10 | % | 13.6 | % | n/a | |||||||
Customer B |
Less than 10 | % | 13.1 | % | 11.0 | % | ||||||
Customer C |
11.3 | % | Less than 10 | % | 20.0 | % | ||||||
Customer D |
10.7 | % | Less than 10 | % | n/a |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
||||||||||||||||||||||
Cost of Sales |
$ | 9.684 | $ | 10.282 | $ | 7.583 | $ | (0.598 | ) | (6 | )% | $ | 2.699 | 36 | % | |||||||||||||
Gross Profit |
15.913 | 16.647 | 10.757 | (0.733 | ) | (4 | )% | 5.890 | 55 | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Gross Margin % |
62.2 |
% |
61.8 |
% |
58.6 |
% |
1 |
% |
3 |
% | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
Expenses |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Salaries, wages and benefits |
$ | 21.692 | $ | 20.885 | $ | 10.314 | $ | 0.807 | 4 | % | $ | 10.571 | 102 | % | ||||||||||||||
Sales and marketing |
1.377 | 1.536 | 3.167 | (0.159 | ) | (10 | )% | (1.631 | ) | (51 | )% | |||||||||||||||||
Research and development |
3.179 | 1.078 | 0.498 | 2.101 | 195 | % | 0.580 | 116 | % | |||||||||||||||||||
General and administration |
8.539 | 5.742 | 3.295 | 2.797 | 49 | % | 2.447 | 74 | % | |||||||||||||||||||
Professional and consulting fees |
9.085 | 8.886 | 4.352 | 0.199 | 2 | % | 4.534 | 104 | % | |||||||||||||||||||
Share-based compensation |
1.868 | 1.454 | 1.468 | 0.414 | 28 | % | (0.014 | ) | — | % | ||||||||||||||||||
Depreciation and amortization |
8.925 | 6.778 | 4.044 | 2.147 | 32 | % | 2.734 | 68 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
54.665 |
$ |
46.360 |
$ |
27.138 |
$ |
8.305 |
18 |
% |
$ |
19.222 |
71 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | General and administration expenses, which typically consist of public company fees, bad debt expense, rent expense, and recruitment costs, increased by 49% or $2.797 million in 2021 compared to 2020, primarily due to an increase in the loss allowance of $1.162 million related to uncollectible receivables, and $1.000 million associated with the Company’s NASDAQ listing, combined with costs associated with a full year of the Company’s ownership of its kanepi subsidiary that were not present in the year ended December 31, 2020. General and administration expenses increased by 74% or $2.447 million for the year ended December 31, 2020 compared to the year ended December 31, 2019, primarily due to facilities and overhead costs associated with a full year of ownership of its subsidiaries including mCloud Technologies Services (“MTS”), acquired in Q3 2019, Construction Systems Associates, Inc. USA (“CSA”), acquired in Q1 2020, and kanepi, acquired in Q4 2020. |
• | Depreciation and amortization expenses increased by 32% or $2.147 million in 2021 compared to 2020, attributable to a full year of amortization of intangibles acquired through business and asset acquisitions in Fiscal 2020. Depreciation and amortization expenses increased by 68% or $2.734 million in 2020 compared to 2019, due to amortization of intangibles assets acquired through acquisitions of Agnity, MTS and CSA. |
• | The Company’s customers use its software to monitor their assets and rely on the Company to provide updates and releases as part of its software maintenance and support services. While the Company has not developed a formal research and development policy, the Company is and has been engaged with a number of research and development initiatives as a part of its ongoing effort to continually update its software and develop new products. Research and development expenses increased by $2.101 million in 2021 compared to 2020, due to ongoing development and investments in AssetCare Mobile, IAQ Badge and 3D technologies. Research and development expenses increased by $0.580 million in 2020 compared to 2019, due to the development of AssetCare project investments. |
• | Professional and consulting expenses increased by $0.199 million in 2021 compared to 2020, due to the Company retaining more consultants for various accounting and professional service functions that were previously performed by employees in 2020, combined with the costs associated with a full year of the Company’s ownership of its kanepi subsidiary. Professional and consulting expenses increased by $4.534 million in 2020 compared to 2019, attributable to professional legal and advisory, as well as accounting and valuation services related to business acquisitions and financings completed during the year. |
• | For the year ended December 31, 2021, salaries, wages and benefits were flat year over year, compared to the same period in 2020. Salaries, wages and benefits increased by 102% or $10.571 million in 2020 compared to 2019, due to higher headcount attributable to acquisitions of CSA and kanepi, combined with added personnel in the asset purchase of AirFusion. |
• | The above noted increases were partially offset by a decrease in the Company’s sales and marketing costs by 10% or $0.159 million due to lower marketing spending early in 2021, as the pandemic curtailed industry activity and the Company elected to spend less. This decrease in spending was partially offset by the mCloud Connect event that took place in 2021. For the year ended December 31, 2020, sales and marketing decreased by 51% or $1.631 million compared to the same period in 2019, due to the curtailment of activities attributable to ongoing COVID-19 restrictions. |
Expenses |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Salaries, wages and benefits |
$ | 21.692 | $ | 20.885 | $ | 10.314 | $ | 0.807 | 4 | % | $ | 10.571 | 102 | % | ||||||||||||||
Sales and marketing |
1.377 | 1.536 | 3.167 | (0.159 | ) | (10) | % | (1.631 | ) | (51) | % | |||||||||||||||||
Research and development |
3.179 | 1.078 | 0.498 | 2.101 | 195 | % | 0.580 | 116 | % | |||||||||||||||||||
General and administration |
8.539 | 5.742 | 3.295 | 2.797 | 49 | % | 2.447 | 74 | % | |||||||||||||||||||
Professional and consulting fees |
9.085 | 8.886 | 4.352 | 0.199 | 2 | % | 4.534 | 104 | % | |||||||||||||||||||
Share-based compensation |
1.868 | 1.454 | 1.468 | 0.414 | 28 | % | (0.014 | ) | — | % | ||||||||||||||||||
Depreciation and amortization |
8.925 | 6.778 | 4.044 | 2.147 | 32 | % | 2.734 | 68 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
54.665 |
$ |
46.360 |
$ |
27.138 |
$ |
8.305 |
18 |
% |
$ |
19.222 |
71 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | Depreciation and amortization expenses increased by 32% or $2.147 million in 2021 compared to 2020, attributable to a full year of amortization of intangibles acquired through business and asset acquisitions in Fiscal 2020. Depreciation and amortization expenses increased by 68% or $2.734 million in 2020 compared to 2019, due to amortization of intangibles assets acquired through acquisitions of Agnity, MTS and CSA. |
• | The Company’s customers use its software to monitor their assets and rely on the Company to provide updates and releases as part of its software maintenance and support services. While the Company has not developed a formal research and development policy, the Company is and has been engaged with a number of research and development initiatives as a part of its ongoing effort to continually update its software and develop new products. Research and development expenses increased by $2.101 million in 2021 compared to 2020, due to ongoing development and investments in AssetCare Mobile, IAQ Badge and 3D technologies. Research and development expenses increased by $0.580 million in 2020 compared to 2019, due to the development of AssetCare project investments. |
• | Professional and consulting expenses increased by $0.199 million in 2021 compared to 2020, due to the Company retaining more consultants for various accounting and professional service functions that were previously performed by employees in 2020, combined with the costs associated with a full year of the Company’s ownership of its kanepi subsidiary. Professional and consulting expenses increased by $4.534 million in 2020 compared to 2019, attributable to professional legal and advisory, as well as accounting and valuation services related to business acquisitions and financings completed during the year. |
• | For the year ended December 31, 2021, salaries, wages and benefits were flat year over year, compared to the same period in 2020. Salaries, wages and benefits increased by 102% or $10.571 million in 2020 compared to 2019, due to higher headcount attributable to acquisitions of CSA and kanepi, combined with added personnel in the asset purchase of AirFusion. |
• | The above noted increases were partially offset by a decrease in the Company’s sales and marketing costs by 10% or $0.159 million due to lower marketing spending early in 2021, as the pandemic curtailed industry activity and the Company elected to spend less. This decrease in spending was partially offset by the mCloud Connect event that took place in 2021. For the year ended December 31, 2020, sales and marketing decreased by 51% or $1.631 million compared to the same period in 2019, due to the curtailment of activities attributable to ongoing COVID-19 restrictions. |
Other expenses (income) |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Finance costs |
$ | 8.619 | $ | 6.034 | $ | 3.218 | $ | 2.585 | 43 | % | $ | 2.816 | 88 | % | ||||||||||||||
Foreign exchange loss (gain) |
(0.267 | ) | 1.198 | 0.494 | (1.465 | ) | (122 | )% | $ | 0.704 | 143 | % | ||||||||||||||||
Impairment of intangible asset |
— | — | 0.601 | — | — | % | $ | (0.601 | ) | (100 | )% | |||||||||||||||||
Business acquisition costs and other expenses |
0.346 | 1.812 | 9.880 | (1.466 | ) | (81 | )% | $ | (8.068 | ) | (82 | )% | ||||||||||||||||
Fair value loss on derivatives |
6.040 | — | — | 6.040 | — | % | $ | — | — | % | ||||||||||||||||||
Other income |
(7.126 | ) | (2.932 | ) | (0.168 | ) | (4.194 | ) | 143 | % | $ | (2.764 | ) | 1645 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ | 7.612 | $ | 6.111 | $ | 14.025 | $ | 1.500 | 25 | % | $ | (7.914 | ) | 4713 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | Finance costs increased by $2.585 million during the year ended December 31, 2021, compared to the same period in 2020, due to increased interest and transaction costs associated with the 2021 Convertible Debentures, which were converted in Q3 2021, along with interest and fees on new borrowings, partially offset by lower interest on repaid borrowings. Finance costs increased by $2.816 million for the year ended December 31, 2020, compared with the same period in 2019, due to higher interest expense on the 2019 Convertible Debentures, with the funds used for business acquisitions. |
• | Foreign exchange was a gain of $0.267 million for the year ended December 31, 2021, compared to a loss of $1.198 million for the same period in 2020, due to an increase in US denominated financings in 2021. For the year ended December 31, 2020, the foreign exchange loss increased by $0.704 million to $1.198 million from $0.494 million for the same period in 2019, as a result of the timing of cash receipts and payments. |
• | During the year ended December 31, 2021, the Company determined that the amount of the contingent consideration recognized at the date of acquisition of CSA would not be payable as the operational performance metrics were not achieved. In addition, the fair value of the contingent consideration recognized at the date of acquisition for kanepi remeasured based on management’s estimate of the likelihood the performance metrics would be met by October 2022, resulting in a decrease in fair value and an offsetting amount recognized as other income, presented as business acquisition costs and other expenses, . For the year ended December 31, 2019, business acquisition costs included $9.870 million incurred as transaction costs in connection with acquisitions including consulting fees, legal and professional fees and fair value of $8.880 million for 800,000 common shares issued for brokering and due diligence services. |
• | Fair value changes in derivatives were a loss of $6.040 million for the year ended December 31, 2021. These are non-cash losses as a result of the conversion of the 2021 Convertible Debenture into common shares and warrants. The initial fair value loss on the convertible debentures along with losses on modification and remeasurement of the financial liability, partially offset by gains on the remeasurement of the warrant liability from date of issuance on August 13, 2021 to December 31, 2021 are the primary drivers of this amount. The additional element of these fair value changes in derivatives relates to the remeasurement of warrant liabilities issued in November 2021, at December 31, 2021. |
• | Other Income increased by $4.194 million for the year ended December 31, 2021, to $7.126 million from $2.932 million for the same period in 2020. The majority of Other Income includes wage and rent subsidies received from the Canadian government and low-interest loans from the US government, which were partially forgiven in 2021 and 2020. Also during the year ended December 31, 2021, contingent consideration associated with the acquisition of CSA and kanepi was determined not to be payable and as such, $1.010 million was recognized in Other Income. For the year ended December 31, 2020, Other Income increase by $2.764 million compared to the same period in 2019, primarily due to wage subsidies and benefits from low-interest loans received from US and Canadian government COVID-19 relief programs. |
Expenses |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Current tax expense (recovery) |
$ | 0.157 | $ | (0.296 | ) | $ | 0.182 | $ | 0.453 | (153 | )% | $ | (0.478 | ) | (262 | )% | ||||||||||||
Deferred tax expense (recovery) |
$ | (1.822 | ) | $ | (0.668 | ) | $ | (2.692 | ) | $ | (1.154 | ) | 173 | % | $ | 2.024 | (75 | )% |
Major Service Line |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
AssetCare Initialization |
$ | 0.173 | $ | 2.672 | $ | (2.499 | ) | (94 | )% | |||||||
AssetCare Over Time |
3.886 | 5.546 | (1.660 | ) | (30 | )% | ||||||||||
Engineering Services |
0.111 | 1.005 | (0.894 | ) | (89 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.170 |
$ |
9.223 |
$ |
(5.053 |
) |
(55 |
)% | |||||||
|
|
|
|
|
|
|
|
Timing of revenue recognition |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Revenue recognized over time |
$ | 4.073 | $ | 4.757 | $ | (0.684 | ) | (14 | )% | |||||||
Revenue recognized at point in time upon completion |
0.097 | 4.466 | (4.369 | ) | (98 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.170 |
$ |
9.223 |
$ |
(5.053 |
) |
(55 |
)% | |||||||
|
|
|
|
|
|
|
|
2021 |
2020 |
Change $ |
Change % |
|||||||||||||
Cost of Sales |
$ | 1.507 | $ | 3.579 | $ | (2.072 | ) | (58 | )% | |||||||
Gross Profit |
2.664 | 5.644 | (2.981 | ) | (53 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Gross margin % |
63.9 |
% |
61.2 |
% |
4 |
% | ||||||||||
|
|
|
|
|
|
Expenses |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Salaries, wages and benefits |
$ | 5.608 | $ | 4.486 | $ | 1.122 | 25 | % | ||||||||
Sales and marketing |
0.400 | 0.304 | 0.096 | 32 | % | |||||||||||
Research and development |
1.105 | 0.323 | 0.782 | 242 | % | |||||||||||
General and administration |
4.187 | 1.924 | 2.263 | 118 | % | |||||||||||
Professional and consulting fees |
2.446 | 2.090 | 0.356 | 17 | % | |||||||||||
Share-based compensation |
0.684 | 0.427 | 0.257 | 60 | % | |||||||||||
Depreciation and amortization |
2.146 | 1.917 | 0.229 | 12 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
16.576 |
$ |
11.471 |
$ |
5.105 |
45 |
% | ||||||||
|
|
|
|
|
|
|
|
• | General and administration expenses increased by 118% or $2.263 million primarily as the result of costs associated with the Company’s NASDAQ listing, which occurred in November 2021, combined with a bad debts provision. |
• | Research and development expenses increased by $0.782 million in Q4 2021 compared with 2020, related specifically to the ongoing development of AssetCare Mobile, “IAQ” Badge and 3D technologies. Spending in prior year was curtailed as a means of conserving cash. |
• | Professional and consulting expenses increased by 17% or $0.356 million, primarily related to increased costs for professional services associated with the general efforts to raise capital to explore current and future acquisition opportunities, perform technical accounting and advisory fees and prepare and file the Company’s prospectus supplements. Consultants filled positions in 2021 that were previously held by employees in 2020. |
• | Salaries, wages and benefits costs increased by 25% or $1.122 million, primarily due to a full year of the costs associated with a full year of the Company’s ownership of its kanepi subsidiary, as compared with the prior year when kanepi was acquired in October 2020. This was partially offset by the use of consultants in 2021 for tasks previously performed by employees in 2020. |
• | Depreciation and amortization non-cash costs increased by 12% or $0.229 million for Q4 2021. These changes were related to intangible assets which were acquired as part of business and assets acquisitions completed throughout Fiscal 2020 acquired from CSA, and the intangible assets acquired as part of the Company’s acquisition of kanepi. |
• | Sales and marketing costs increased by 32% mainly as a result of investments by the Company to explore opportunities in the AssetCare solutions across all industries and in particular, in the IAQ space. |
Other expenses (income) |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Finance costs |
$ | 2.724 | $ | 1.694 | $ | 1.030 | 61 | % | ||||||||
Foreign exchange loss (gain) |
(0.041 | ) | 1.583 | (1.624 | ) | (103 | )% | |||||||||
Business acquisition costs and other expenses |
0.023 | 0.501 | (0.478 | ) | (95 | )% | ||||||||||
Fair value gain on derivatives |
(3.075 | ) | — | (3.075 | ) | — | % | |||||||||
Other income |
(1.654 | ) | (0.971 | ) | (0.683 | ) | 70 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
(2.023 |
) |
$ |
2.807 |
$ |
(4.830 |
) |
(172 |
)% | ||||||
|
|
|
|
|
|
|
|
• | Finance costs increased by $1.030 million for the three months ended December 31, 2021, due to higher interest and fees on new borrowings. |
• | Foreign exchange changed from a loss of $1.583 million for the comparative period in 2020 to a gain of $0.041 million in Q4 2021. These movements were the result of the timing of cash receipts and payments, combined with the USD public offering that closed in the last quarter of 2021. |
• | Fair value changes in derivatives constituted a gain of $3.075 million for the three months ended December 31, 2021. These non-cash changes relate to the fair value adjustment for the warrants and was partially offset by the remeasurement of warrant liabilities, issued in November 2021, being revalued at December 31, 2021. |
• | Other Income increased by $0.683 million for the three months ended December 31, 2021. The majority of Other Income includes wage and rent subsidies received from the Canadian government and low-interest loans from the US government which have been partially forgiven in the periods. |
Expenses |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Current tax expense (recovery) |
$ | (0.704 | ) | $ | (0.397 | ) | $ | (0.307 | ) | 77 | % | |||||
Deferred tax expense (recovery) |
$ | (0.854 | ) | $ | 0.682 | $ | (1.535 | ) | (225 | )% |
For the quarter ended: |
Q4 2021 |
Q3 2021 (1) |
Q2 2021 (1) |
Q1 2021 (1) |
Q4 2020 |
Q3 2020 |
Q2 2020 |
Q1 2020 |
||||||||||||||||||||||||
Total revenue |
$ | 4.171 | $ | 7.434 | $ | 6.556 | $ | 7.436 | $ | 9.223 | $ | 6.137 | $ | 5.010 | $ | 6.558 | ||||||||||||||||
Net loss |
10.331 | 15.616 | 9.000 | 9.752 | 8.918 | 8.713 | 9.353 | 7.878 | ||||||||||||||||||||||||
Net loss - mCloud shareholders |
9.662 | 15.466 | 8.930 | 10.271 | 9.725 | 9.417 | 9.707 | 8.021 | ||||||||||||||||||||||||
Basic and diluted loss per share |
$ | 0.70 | $ | 1.22 | $ | 0.88 | $ | 1.12 | $ | 1.07 | $ | 1.15 | $ | 1.53 | $ | 1.47 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total assets |
$ |
72.106 |
$ |
73.818 |
$ |
79.868 |
$ |
75.803 |
$ |
77.319 |
$ |
68.113 |
$ |
64.349 |
$ |
67.869 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total non- current financial liabilities |
$ |
1.513 |
$ |
12.978 |
$ |
24.565 |
$ |
43.440 |
$ |
33.443 |
$ |
33.319 |
$ |
37.223 |
$ |
32.795 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | March 31, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.945 million ($0.10 per share); |
• | June 30, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.652 million ($0.13 per share); |
• | September 30, 2021, increased revenue and decreased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.098 million ($0.01 per share). |
Cash provided by (used in): |
2021 |
2020 |
2019 |
|||||||||
Operating activities |
$ | (28.330 | ) | $ | (24.856 | ) | $ | (14.516 | ) | |||
Investing activities |
(1.064 | ) | (6.395 | ) | (20.732 | ) | ||||||
Financing activities |
32.927 | 31.857 | 34.465 | |||||||||
|
|
|
|
|
|
|||||||
Increase in cash, before effect of exchange rate fluctuation |
$ |
3.533 |
$ |
0.606 |
$ |
(0.784 |
) | |||||
|
|
|
|
|
|
At December 31, 2021 |
Undiscounted Contractual Cash Flows |
|||||||||||||||
Contractual Obligations |
< 1 year |
1 – 2 years |
> 2 years |
Total |
||||||||||||
Bank indebtedness 1 |
$ | 3.460 | $ | — | $ | — | $ | 3.460 | ||||||||
Trade payables and accrued liabilities |
12.421 | — | — | 12.421 | ||||||||||||
Loans and borrowings 2 |
11.764 | 0.786 | — | 12.550 | ||||||||||||
Lease liabilities 3 |
0.522 | 0.534 | 0.179 | 1.235 | ||||||||||||
2019 Convertible Debentures |
24.630 | — | — | 24.630 | ||||||||||||
2021 Convertible Debentures |
0.008 | 0.103 | — | 0.111 | ||||||||||||
Warrant liabilities 5 |
0.710 | — | — | 0.710 | ||||||||||||
Business acquisition payable |
1.399 | — | — | 1.399 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Contractual obligations |
$ |
54.913 |
$ |
1.423 |
$ |
0.179 |
$ |
56.516 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
At December 31, 2021 |
Undiscounted Contractual Cash Flows |
|||||||||||||||||||
Commitments |
< 1 year |
2 – 3 years |
4 – 5 years |
More than 5 years |
Total |
|||||||||||||||
Variable lease payments 5 |
0.397 | 0.478 | 0.125 | 0.013 | 1.013 | |||||||||||||||
Lease payments related to leases which have not yet commenced 6 |
0.105 | 2.589 | 2.763 | 12.636 | 18.093 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commitments |
$ |
0.501 |
$ |
3.067 |
$ |
2.888 |
$ |
12.649 |
$ |
19.106 |
||||||||||
|
|
|
|
|
|
|
|
|
|
1 |
No contractual maturity, due on demand. Excludes interest charged on facility. |
2 |
Includes term loan with a carrying value of $9.276 classified as current due to covenant breach. Assuming term loan is repaid in accordance with agreement to maturity, the undiscounted contractual cash flows for loans and borrowings would be $2.934 million, $5.472 million, and $4.144 million, respectively for the periods presented above. |
3 |
Variable costs payable under lease agreements are not included in this amount. Minimum payment related to leases which have not yet commenced are not included in this amount. |
4 |
Majority of liability will be settled by issuing common shares when warrants are exercised during the year. The remaining amount may be settled in cash or common shares of Agnity. |
5 |
Variable lease payments associated with lease liabilities. |
6 |
In October 2021, the Company executed a 12-year lease for office space in Calgary, Alberta. Base rent and estimated common expense payments commence in December 2022, preceded by a fixturing period which the Company will use to build out the space. The Company will receive a tenant improvement allowance which is expected to cover the majority of the costs. |
For the quarter ended: |
Q1 2022 |
Q4 2021 |
Q3 2021 (1) |
Q2 2021 (1) |
Q1 2021 (1) |
Q4 2020 |
Q3 2020 |
Q2 2020 |
||||||||||||||||||||||||
Total Revenue |
4.430 | 4.171 | 7.434 | 6.556 | 7.436 | 9.223 | 6.137 | 5.010 | ||||||||||||||||||||||||
Net loss |
11.023 | 10.331 | 15.616 | 9.000 | 9.752 | 8.918 | 8.713 | 9.353 | ||||||||||||||||||||||||
Net Loss - mCloud shareholders |
9.778 | 9.662 | 15.466 | 8.930 | 10.271 | 9.725 | 9.417 | 9.707 | ||||||||||||||||||||||||
Basic and diluted loss per share |
$ | 0.61 | $ | 0.70 | $ | 1.22 | $ | 0.88 | $ | 1.12 | $ | 1.07 | $ | 1.15 | $ | 1.53 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total assets |
73.091 |
72.106 |
73.818 |
79.868 |
75.803 |
77.319 |
68.113 |
64.349 |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total non- current financial liabilities |
7.532 |
1.513 |
12.978 |
24.565 |
43.440 |
33.443 |
33.319 |
37.223 |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The results for each of the quarters ended March 31, June 30 and September 30, 2021 have been adjusted for an immaterial error correction which impacted revenue, current and non-current long-term accounts receivables; deferred revenue, and correspondingly, impacted net loss and net loss attributable to mCloud shareholders and related loss per share attributable to mCloud shareholders - basic and diluted. During the quarters ended: |
• |
March 31, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.945 million ($0.10 per share); |
• |
June 30, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.652 million ($0.13 per share); |
• |
September 30, 2021, increased revenue and decreased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.098 million ($0.01 per share). |
2022 |
2021 |
Change $ |
Change % |
|||||||||||||
Revenue Cost of Sales |
$ |
4.430 (1.932 |
) |
$ |
7.436 (3.259 |
) |
$ |
(3.006 1.327 |
) |
|
(40 (41 |
)% )% | ||||
|
|
|
|
|
|
|
|
|||||||||
Gross Profit |
$ |
2.497 |
$ |
4.177 |
$ |
(1.680 |
) |
(40 |
)% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Expenses |
||||||||||||||||
Salaries, wages and benefits |
$ | 5.314 | $ | 4.870 | $ | 0.444 | 9 | % | ||||||||
Sales and marketing |
0.762 | 0.185 | 0.577 | 312 | % | |||||||||||
Research and development |
0.532 | 0.749 | (0.217 | ) | (29 | )% | ||||||||||
General and administrative |
2.552 | 1.337 | 1.215 | 91 | % | |||||||||||
Professional and consulting fees |
3.176 | 1.739 | 1.437 | 83 | % | |||||||||||
Share-based compensation |
0.253 | 0.375 | (0.122 | ) | (33 | )% | ||||||||||
Depreciation and amortization |
1.943 | 1.971 | (0.028 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
$ | 14.533 | $ | 11.227 | $ | 3.306 | 29 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
$ |
12.035 |
$ |
7.050 |
$ |
4.985 |
71 |
% | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other Expenses (income) |
||||||||||||||||
Finance costs |
$ | 1.859 | $ | 2.236 | $ | (0.377 | ) | (17 | )% | |||||||
Foreign exchange loss |
0.623 | 0.367 | 0.256 | 70 | % | |||||||||||
Business acquisition costs and other expenses |
— | 0.324 | (0.324 | ) | (100 | )% | ||||||||||
Fair value (gain) loss on derivatives |
(2.493 | ) | 1.564 | (4.057 | ) | (259 | )% | |||||||||
Other income |
(0.398 | ) | (1.910 | ) | 1.512 | (79 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before tax |
$ |
11.625 |
$ |
9.632 |
$ |
1.993 |
21 |
% | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Current tax expense |
$ | 0.289 | $ | 0.239 | $ | 0.050 | 21 | % | ||||||||
Deferred tax recovery |
(0.891 | ) | (0.119 | ) | (0.772 | ) | 647 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss for the period |
$ |
11.023 |
$ |
9.752 |
$ |
1.271 |
13 |
% | ||||||||
|
|
|
|
|
|
|
|
Major Service Line |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
AssetCare initialization |
$ | 0.415 | $ | 0.515 | $ | (0.100 | ) | (20 | )% | |||||||
AssetCare over time |
3.989 | 6.435 | (2.446 | ) | (38 | )% | ||||||||||
Engineering services |
0.026 | 0.486 | (0.460 | ) | (95 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.430 |
$ |
7.436 |
$ |
(3.006 |
) |
(40 |
)% | |||||||
|
|
|
|
|
|
|
|
Timing of revenue recognition |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
Revenue recognized over time |
$ | 3.862 | $ | 5.449 | $ | (1.587 | ) | (29 | )% | |||||||
Revenue recognized at point in time upon completion |
$ | 0.568 | 1.987 | (1.419 | ) | (71 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.430 |
$ |
7.436 |
$ |
(3.006 |
) |
(40 |
)% | |||||||
|
|
|
|
|
|
|
|
2022 |
2021 |
Change $ |
Change % |
|||||||||||||
Cost of Sales |
$ | 1.932 | $ | 3.259 | $ | (1.326 | ) | (41 | )% | |||||||
Gross Profit |
2.497 | 4.177 | (1.680 | ) | (40 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross margin % |
56.4 |
% |
56.2 |
% |
— |
% | ||||||||||
|
|
|
|
|
|
|
|
Expenses |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
Salaries, wages and benefits |
$ | 5.314 | $ | 4.870 | $ | 0.444 | 9 | % | ||||||||
Sales and marketing |
0.762 | 0.185 | 0.577 | 312 | % | |||||||||||
Research and development |
0.532 | 0.749 | (0.217 | ) | (29 | )% | ||||||||||
General and administration |
2.552 | 1.337 | 1.215 | 91 | % | |||||||||||
Professional and consulting fees |
3.176 | 1.739 | 1.437 | 83 | % | |||||||||||
Share-based compensation |
0.253 | 0.375 | (0.122 | ) | (33 | )% | ||||||||||
Depreciation and amortization |
1.943 | 1.971 | (0.028 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
14.533 |
$ |
11.227 |
$ |
3.306 |
29 |
% | ||||||||
|
|
|
|
|
|
|
|
• | Professional and consulting expenses increased by 83% or $1.437 million, primarily related to increased costs for professional services in Q1 2022. Consultants also filled positions in Q2 2021 that were previously held by employees. |
• | General and administration expenses increased by 91% or $1.215 million primarily due to increased insurance premiums following the Company’s NASDAQ listing in Q4 2021, combined with increased IT subscriptions as the Company ramps up to return its resources to pre-COVID 19 levels. |
• | Sales and marketing costs increased by 312% or $0.577 million, due to sponsorships with the Mercedes-Benz Formula E Limited racing team and increased marketing initiatives in Q1 2022. |
• | Salaries, wages and benefits costs increased by 9% or $0.444 million, primarily attributable to increased headcount related to the Company’s post COVID-19 expansion, ramping up for expected growth later in 2022. |
• | Research and development expenses decreased by $0.217 million in Q1 2022 compared with the same period in 2021, as a means of conserving cash in Q1 2022. Research and development specifically relates to the ongoing development of AssetCare Mobile, “IAQ” Badge and 3D technologies. |
• | Depreciation and amortization non-cash costs decreased by 1% or $0.028 million for Q1 2022, due to a decrease in new assets for property and equipment, combined with fully depreciated assets at or nearing the end of their useful life. |
Other expenses (income) |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
Finance costs |
$ | 1.859 | $ | 2.236 | $ | (0.377 | ) | (17 | )% | |||||||
Foreign exchange loss (gain) |
0.623 | 0.367 | 0.256 | 70 | % | |||||||||||
Business acquisition costs and other expenses |
— | 0.324 | (0.324 | ) | (100 | )% | ||||||||||
Fair value (gain) loss on derivatives |
(2.493 | ) | 1.564 | (4.057 | ) | (259 | )% | |||||||||
Other income |
(0.398 | ) | (1.910 | ) | 1.512 | (79 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
(0.410 |
) |
$ |
2.582 |
$ |
(2.990 |
) |
(116 |
)% | ||||||
|
|
|
|
|
|
|
|
• | Fair value changes in derivatives were a gain of $2.493 million for the three months ended March 31, 2022. These are non-cash gains as a result of the remeasurement of the warrant liabilities at March 31, 2022. The warrant liabilities include the warrants issued on conversion of the 2021 Convertible Debenture and the warrant liabilities issued in November 2021. |
• | Finance costs decreased by $0.377 million during the three months ended March 31, 2022, compared to the same period in 2021, primarily due to transaction costs on the issuance of convertible debentures expensed in Q1 2021. |
• | There were no business acquisition costs in either Q1 2022 or Q1 2021. Other expenses vary depending on activity. |
• | Other Income decreased by $1.512 million for the three months ended March 31, 2022, to $0.398 million from $1.910 million for the same period in 2021. The majority of Other Income includes wage and rent subsidies for COVID-19 programs received from the Canadian government and low-interest loans from the US government. The majority of these programs have now ended. |
• | Foreign exchange was a loss of $0.623 million for the three months ended March 31, 2022, compared to a loss of $0.367 million for the same period in 2021, due to a stronger Canadian dollar. |
Cash provided by (used in): |
2022 |
2021 |
||||||
Operating activities |
$ | (3.771 | ) | $ | (4.930 | ) | ||
Investing activities |
(0.011 | ) | (0.461 | ) | ||||
Financing activities |
1.090 | 4.608 | ||||||
|
|
|
|
|||||
Increase in cash, before effect of exchange rate fluctuation |
$ |
(2.692 |
) |
$ |
(0.783 |
) | ||
|
|
|
|
• | the plans for the repayment of the 2019 Convertible Debentures; |
• | the repayment of a portion of the term loan on May 6, 2022 and the agreement executed whereby the term loan will be repaid in full on or before October 31, 2022; |
• | the likelihood that undrawn funds under the revolving operating facility will be available and will not be required to be repaid; |
• | the required cash principal and interest payments on indebtedness; |
• | the likelihood of payments required under contingent consideration arrangements; |
• | the available funding of US$15 million under a promissory note executed on March 28, 2022; |
• | cash inflows from current operations, expected government assistance in the form of wage and rent subsidies, and expected increases in revenues and cash flows resulting from new revenue contracts expected over the next 12 months due to the anticipated reduction of COVID-19 related restrictions; and |
• | future debt and equity raises. |
Three months ended March 31, |
2022 |
2021 |
Change % |
|||||||||
Salaries, fees and short-term benefits |
$ | 0.399 | $ | 0.374 | 7 | % | ||||||
Share-based compensation |
0.121 | 0.057 | 112 | % | ||||||||
|
|
|
|
|
|
|||||||
$ |
0.520 |
$ |
0.431 |
21 |
% | |||||||
|
|
|
|
|
|
• | An ineffective control environment resulting from an insufficient number of trained financial reporting and accounting, information technology (IT) and operational personnel with the appropriate skills and knowledge and with assigned responsibility and accountability related to the design, implementation and operating effectiveness of internal control over financial reporting. |
• | The insufficient number of personnel described above contributed to an ineffective risk assessment process necessary to identify all relevant risks of material misstatement and to evaluate the implications of relevant risks on its internal control over financial reporting. |
• | An ineffective information and communication process resulting from (i) insufficient communication of internal control information, including objectives and responsibilities, such as delegation of authority; and (ii) ineffective general IT controls and ineffective controls related to spreadsheets, resulting in insufficient controls to ensure the relevance, timeliness and quality of information used in control activities. |
• | As a consequence of the above and as a result of inadequate segregation of duties and secondary review, the Company had ineffective control activities related to the design, implementation and operating effectiveness of process level and financial reporting controls which had a pervasive impact on the Company’s internal control over financial reporting. |
• | An ineffective monitoring process resulting from the evaluation and communication of internal control deficiencies, including monitoring corrective actions, not being performed in a timely manner. |
• | Identifying key positions necessary to support the Company’s initiatives related to internal controls over financial reporting, and expanding its hiring efforts accordingly. |
• | Hiring consultants to assist with process improvements and control remediation efforts in targeted accounting, IT and operations processes. |
• | Formalizing its entity-wide risk assessment process, and documenting internal ownership of risk monitoring and mitigation efforts, with improved risk monitoring activities and regular reporting to those charged with governance at an appropriate frequency. |
• | Finalize a delegation of authority matrix to enforce desired limits of authority for key transactions, events, and commitments, and communicating these limits of authority to relevant personnel throughout the Company. |
• | Further simplify and streamline its spreadsheet models to reduce the risk of errors in mathematical formulas and improve the ability to verify the logic of spreadsheets. |
• | Hiring a consultant to assist management with process improvements and control remediation for general IT controls. |
• | Continuing to perform scoping exercises and planning for an ERP implementation to streamline the number of applications used for financial reporting activities. |
Securities Outstanding |
||||
Shares issued and outstanding |
16,155,654 |
|||
Share purchase warrants (1) |
8,665,406 |
|||
Stock options |
870,146 |
|||
Restricted share units |
251,265 |
|||
2019 Convertible Debentures (2) |
1,563,833 |
|||
2021 Convertible Debentures (3) |
15,750 |
|||
|
|
|||
Total |
27,522,054 |
|||
|
|
(1) |
Share purchase warrants offer the holder the right to purchase a common share of the Company at a specified price by a specific date. Share purchase warrants outstanding have exercise prices ranging from Canadian dollar equivalent at date of issuance between $4.12 - $22.50 and a weighted average remaining contractual life of 2.6 years. |
(2) |
Debentures are convertible at the option of the holder and have a conversion price of $15.00 and mature June 30, 2022. |
(3) |
Debentures are convertible at the option of the holder and have a conversion price of $5.98 which has been converted to Canadian dollars at May 12, 2022. The Debentures have a remaining life to maturity of 1.6 years. |
* | Despite owning no shares, or having any voting rights, the Company determined that it exercises control over Agnity Global, Inc. (“Agnity”) as the Company has the right to nominate a majority of the members of Agnity’s Operations Committee and therefore the right and ability to direct the relevant activities of Agnity and to significantly affect its returns through the use of its rights. As a result, the financial results of Agnity have been consolidated into the Company’s financial statements. |
• | HVAC units and refrigerators in commercial buildings; |
• | control systems, heat exchangers, and compressors at process industry facilities; and |
• | wind turbines generating renewable energy at onshore wind farms. |
• | curbing wasted energy while improving occupant comfort in commercial facilities through AI-powered adaptive control; |
• | maximizing asset availability and production yields of renewable energy sources through continuous performance assessment and predictive maintenance; and |
• | optimizing the uptime and manage the operational risk of industrial process plants, including oil and gas facilities, through continuous AI-powered advisory and assistance to process operators in the field. |
1) | Connected Buildings |
2) | Connected Workers AI-powered “digital assistant”; |
3) | Connected Energy AI-powered computer vision and the deployment of analytics to improve wind farm energy production yield and availability; |
4) | Connected Industry |
5) | Connected Health in-person visits, including at elder care facilities, age-in-place |
Patent |
Patent No. / App. Serial No. |
Jurisdiction |
Date Issued / Date Filed |
Status |
Registered Owner | |||||
Apparatus and method for detecting faults and providing diagnostics in vapor compression cycle equipment |
6,658,373 | US Patent | 12/2/2003 | Live | Field Diagnostic Services, Inc. | |||||
Estimating operating parameters of vapor compression cycle equipment |
6,701,725 | US Patent | 3/9/2004 | Live | Field Diagnostic Services, Inc. | |||||
Estimating evaporator airflow in vapor compression cycle cooling equipment |
6,973,793 | US Patent | 12/13/2005 | Live | Field Diagnostic Services, Inc. | |||||
Apparatus and method for detecting faults and providing diagnostics in vapor compression cycle equipment |
7,079,967 | US Patent | 7/18/2006 | Live | Field Diagnostic Services, Inc. | |||||
Method for Determining Evaporator Airflow Verification |
8,024,938 | US Patent | 9/27/2011 | Live | Field Diagnostic Services, Inc. | |||||
Method and Apparatus for Transforming Polygon Data to Voxel Data for General Purpose Applications |
6,867,774 | US Patent | 3/15/2005 | Live | NGRAIN (Canada) Corporation | |||||
Method and System for Rendering Voxel Data while Addressing Multiple Voxel Set Interpenetration |
7,218,323 | US Patent | 5/15/2007 | Live | NGRAIN (Canada) Corporation | |||||
Method and Apparatus for Transforming Point Cloud Data to Volumetric Data |
7,317,456 | US Patent | 1/8/2008 | Live | NGRAIN (Canada) Corporation | |||||
Method, System and Data Structure for Progressive Loading and Processing of a 3D Dataset |
7,965,290 | US Patent | 6/21/2011 | Live | NGRAIN (Canada) Corporation |
Method and System for Calculating Visually Improved Edge Voxel Normals when Converting Polygon Data to Voxel Data |
8,217,939 | US Patent | 7/16/2012 | Live | NGRAIN (Canada) Corporation | |||||
System and Method for Optimal Geometry Configuration Based on Parts Exclusion | 9,159,170 | US Patent | 10/13/2015 | Live | NGRAIN (Canada) Corporation | |||||
Method and System for Emulating Kinematics | 9,342,913 | US Patent | 5/17/2016 | Live | NGRAIN (Canada) Corporation | |||||
System, Computer- Readable Medium and Method for 3D Differencing of 3D Voxel Models | 9,600,929 | US Patent | 3/21/2017 | Live | NGRAIN (Canada) Corporation | |||||
System, Method and Computer-Readable Medium for Organizing and Rendering 3D Voxel Models in a Tree Structure |
9,754,405 | US Patent | 9/10/2015 | Live | NGRAIN (Canada) Corporation | |||||
Portable apparatus and method for decision support for real time automated multisensor data fusion and analysis | 10,346,725 072239.0004 / BR BR 11 2017 024598 1 072239.0005 / MX MX/a/2017/014648 072239.0006 / EU EP16797087.0 072239.0007 / IN 201747045184 072239.0008 / CN 2016800413571 072239.0009 / CA 072239.0010 / ZA 2018/01638 |
US Patent National Stage Filings in BR / MX / EU / IN / CN / CA / ZA |
7/9/2019 | Live | mCloud Corp. |
Trademark |
App. Serial No. / Reg. No. |
Date Issued / Date Filed |
Status |
Registered Owner | ||||
ACRx | 75281276/ 2492872 |
9/25/2001 |
Live | Field Diagnostic Services, Inc. | ||||
MCLOUD CORP (standard mark) | 87327278/ 5333557 |
14/11/2017 |
Live | mCloud Corp. | ||||
mCloud Corp (design mark) |
87327435/ 5333558 |
14/11/2017 |
Live | mCloud Corp. | ||||
Asset Circle of Care (standard mark) | 87327483/ 5333559 |
14/11/2017 |
Live | mCloud Corp. | ||||
AssetCare (standard mark) | 87327512/ 5333560 |
11/14/2017 |
Live | mCloud Corp. | ||||
3KO | 77398780/ 3796217 |
11/11/2008 |
Live | NGRAIN (Canada) Corporation | ||||
NGRAIN (design mark) |
77912373/ 3840652 |
6/15/2010 |
Live | NGRAIN (Canada) Corporation | ||||
NGRAIN (design mark) |
009245101 (EU) | 12/27/2010 |
Live | NGRAIN (Canada) Corporation | ||||
PRODUCER | 009327412 (EU) | 2/3/2011 |
Live | NGRAIN (Canada) Corporation | ||||
NGRAIN (standard mark) | 78199527/ 2881383 |
9/7/2004 |
Live | NGRAIN (Canada) Corporation | ||||
mCloud Connect (standard mark) |
5756945 | 5/21/2019 |
Live | mCloud Corp. | ||||
mCloud (design mark) |
88/907693 | In Application (Approved) | ||||||
mCloud (design mark) |
88/907606 | In Application (Approved) | ||||||
AssetCare (design mark) | 88/907679 | In Application (Approved) | ||||||
PanoMap (standard mark) | 88/916707 6,444,185 |
8/10/2021 |
Live | mCloud Corp. | ||||
Newton Engine (standard mark) | 88/907682 | In Application (Approved) | ||||||
Kanepi | 40201608870Y / SG | June 1 2016 | Live | Kanepi Pte Ltd | ||||
40201608871T / SG | June 1 2016 | Live | Kanepi Pte Ltd | |||||
SEE YOUR BUSINESS | 2024268 / AUS | March 11 2020 | Live | Kanepi Pte Ltd | ||||
MY LDAR (standard mark) | 97264404 | February 11, 2020 |
In Application | mCloud Corp. | ||||
97264407 | February 11, 2020 |
In Application | mCloud Corp. |
Name |
Age |
Position |
Appointed | |||||
Russel H. McMeekin |
56 | Chief Executive Officer, President, Director | October 2017 | |||||
Michael Allman |
61 | Director | October 2017 | |||||
Costantino Lanza |
68 | Chief Growth Officer, Corporate Secretary, Director | October 2017 | |||||
Elizabeth MacLean |
57 | Director | October 2018 | |||||
Ian Russell |
73 | Director | September 2019 | |||||
Chantal Schutz |
48 | Chief Financial Officer | May 2019 |
• | an understanding of the accounting principles used by the Company to prepare the Company’s financial statements; |
• | the ability to assess the general application of the above-noted principles in connection with estimates, accruals and reserves; |
• | experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising individuals engaged in such activities; and |
• | an understanding of internal controls and procedures for financial reporting. |
Fees billed for the fiscal year ended December 31, |
||||||||
Service Retained |
2021 |
2020 |
||||||
Audit fees (1) |
CAD$ | 1,799,383 | CAD$ | 769,826 | ||||
Audit-related fees (2) |
CAD$ | 6,420 | CAD$ | — | ||||
Tax fees (3) |
CAD$ | 339,624 | CAD$ | 321,050 | ||||
All other fees (4) |
CAD$ | 102,720 | CAD$ | 38,873 | ||||
|
|
|
|
|||||
Total |
CAD$ | 2,248,147 | CAD$ | 1,129,749 |
1. | Includes fees necessary to perform the annual audit of our consolidated financial statements, reviews of the interim financial statements, and services related to prospectus filings. |
2. | Includes other audit related services that are performed by the auditor. |
3. | Includes fees for tax compliance, tax planning and tax advice. These services include preparing tax returns and corresponding with government tax authorities. |
4. | Includes French translation services related to prospectus filings and historical financial statements and management’s discussion and analysis. |
• | to attract, retain and motivate talented executives who create and sustain the Corporation’s continued success; |
• | to align the interests of the Corporation’s executives with the interests of the Corporation’s shareholders; and |
• | to provide total compensation to executives that is competitive with that paid by other companies of comparable size engaged in similar businesses in appropriate regions. |
(a) | base salaries; |
(b) | performance bonuses; and |
(b) | equity incentive grants. |
• | developing and recommending to the Board criteria for selecting board and committee members; |
• | establishing procedures for identifying and evaluating director candidates, including nominees recommended by shareholders; |
• | identifying individuals qualified to become board members; |
• | recommending to the Board the persons to be nominated for election as directors and to each of the Board’s committees; |
• | reviewing and making recommendations to the Board regarding the appointment and succession of our directors and officers; |
• | developing and recommending to the Board a code of business conduct and ethics and a set of corporate governance guidelines; and |
• | overseeing the evaluation of the Board, its committees and our management. |
• | meeting with our technical management team at least once per calendar quarter; |
• | assessing whether the product delivery schedule is being met and whether it needs to be adjusted; |
• | ensuring that all third-party software we use is properly licensed; |
• | making recommendations to the Board concerning our technology strategy, roadmap and investment plans; |
• | assessing the health and oversight of the execution of our technology strategies; including architecture, use of open source software, development best practices and third-party dependencies; |
• | ensuring that best practice Q&A policies and procedures are in place and are adhered to; |
• | assessing the scope and quality of our intellectual property, including its support of our approved business plan; |
• | providing guidance on technology as it may pertain to market entry and exit, investments, mergers, acquisitions and divestitures, research and development investments, and key competitor and partnership strategies; |
• | performing such other duties and responsibilities as are enumerated in and consistent with its charter |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Committee or meeting fees ($) |
Value of perquisites ($) |
All other compensation ($) |
Total compensation ($) |
|||||||||||||||||||||
Russel H. McMeekin (1) Director, President and Chief Executive Officer |
2021 | $ | 249,999.84 USD | Nil | Nil | Nil | $ | 93,500 USD | $ | 343,499.84 USD | ||||||||||||||||||
Costantino Lanza (2) Director and Chief Growth Officer |
2021 | $ | 249,999.84 USD | Nil | Nil | Nil | $ | 42,358 USD | $ | 292,357 USD | ||||||||||||||||||
Chantal Schutz Chief Financial Officer |
2021 | $ | 262,000 CAD | Nil | Nil | Nil | Nil | $ | 262,000 CAD | |||||||||||||||||||
Michael Allman Director |
2021 | Nil | Nil | $ | 48,000 USD | Nil | Nil | $ | 48,000 USD | |||||||||||||||||||
Elizabeth MacLean Director |
2021 | Nil | Nil | $ | 48,000 USD | Nil | Nil | $ | 48,000 USD | |||||||||||||||||||
Ian Russell Director |
2021 | Nil | Nil | $ | 48,000 USD | Nil | Nil | $ | 48,000 USD | |||||||||||||||||||
Michael A. Sicuro (3) |
2021 | Nil | Nil | $ | 20,000 USD | Nil | Nil | $ | 20,000 USD |
(1) | Inclusive of the total compensation, Mr. McMeekin received no compensation for his role as director of the Company. |
(2) | Inclusive of the total compensation, Mr. Lanza received no compensation for his role as director of the Company. |
(3) | Mr. Sicuro resigned effective as of May 31, 2021. |
Name and Principal Position |
Type of Security |
Number of Compensation Securities, Number of Underlying Securities, and Percentage of Class(1) |
Date of Issue or Grant |
Issue, Conversion or Exercise Price ($) |
Closing Price of Security or Underlying Security on Date of Grant ($) |
Closing Price of Security or Underlying Security at Year End ($) |
Expiry Date | |||||||||||||
Russel H. McMeekin |
Stock Options | 25,000 | October 24, 2019 | Exercise price $12.90 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Russel H. McMeekin |
RSU’s | 50,000 | April 12, 2018 | $9.75 CAD | $ | 9.75 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Russel H. McMeekin |
RSU’s | 25,000 | October 24, 2019 | $12.30 CAD | $ | 12.30 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Costantino Lanza |
Stock Option | 12,500 | October 24, 2019 | Exercise price $12.90 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Costantino Lanza |
RSU’s | 3,333 | April 12, 2018 | $9.75 CAD | $ | 9.75 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Costantino Lanza |
RSU’s | 12,500 | October 24, 2019 | $12.30 CAD | $ | 12.30 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Michael A. Sicuro |
RSU’s | 6,667 | April 12, 2018 | $9.75 CAD | $ | 9.75 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Ian Russel |
Stock Option | 5,000 | October 24, 2019 | Exercise price $11.85 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Chantal Schutz |
Stock Option | 8,333 | October 24, 2019 | Exercise Price $11.70 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Chantal Schutz |
Stock Option | 8,333 | July 31, 2021 | Exercise Price $7.65 |
$ | 7.65 CAD | $ | 6.10 CAD | July 31, 2031 | |||||||||||
Chantal Schutz |
Stock Option | 28,800 | October 22, 2021 | Exercise Price $6.99 |
$ | 6.99 CAD | $ | 6.10 CAD | October 22, 2031 | |||||||||||
Chantal Schutz |
Stock Option | 733 | Jan 1, 2022 | Exercise Price $6.99 |
$ | 6.32 CAD | $ | 6.10 CAD | Jan 1, 2032 | |||||||||||
Chantal Schutz |
RSU’s | 8,333 | October 24, 2019 | $12.30 CAD | $ | 12.30 CAD | $ | 6.10 CAD | No Expiry | |||||||||||
Chantal Schutz |
RSU’s | 8,333 | July 31, 2021 | $7.65 CAD | $ | 7.65 CAD | $ | 6.10 CAD | No Expiry |
• | to attract, retain and motivate talented executives who create and sustain our continued success; |
• | to align our interests with the interests of our shareholders; and |
• | to provide total compensation to executives that is competitive with that paid by other companies of comparable size engaged in similar businesses in appropriate regions. |
a) | base salaries; |
b) | performance bonuses; and |
c) | equity incentive grants. |
Name |
Position | |
Russel H. McMeekin |
Chief Executive Officer, President, Director | |
Michael Allman |
Director | |
Costantino Lanza |
Chief Growth Officer, Corporate Secretary, Director | |
Elizabeth MacLean |
Director | |
Ian Russell |
Director | |
Chantal Schutz |
Chief Financial Officer |
• | each shareholder known by us to be the beneficial owner of more than 5% of our outstanding Common Shares, |
• | each of our directors, |
• | each of our named executive officers, and |
• | all of our directors and executive officers as a group. |
Beneficial Ownership |
||||||||||||||||
Prior to Offering |
Following Offering(1) |
|||||||||||||||
Name of Beneficial Owner |
Common Shares |
Percentage |
Common Shares |
Percentage |
||||||||||||
Russel H. McMeekin |
229,538 | 1.42 | % | 229,538 | * | % | ||||||||||
Michael Allman |
135,157 | * | % | 135,157 | * | % | ||||||||||
Costantino Lanza |
182,845 | 1.13 | % | 182,845 | * | % | ||||||||||
Elizabeth MacLean |
0 | 0 | % | 0 | 0 | % | ||||||||||
Ian Russell |
18,702 | * | % | 18,702 | * | % | ||||||||||
Chantal Schutz |
8,808 | * | % | 8.808 | * | % | ||||||||||
All officers and directors as a group |
|
|
|
|
|
|
|
|
|
|
|
|
* | Less than 1% |
(1) | Calculated assuming full conversion of all Series A Preferred Shares into Common Shares |
Underwriter |
Series A Preferred Shares |
Warrants |
||||||
Maxim Group LLC |
||||||||
American Trust Investment Services Inc. |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
• | receipt and acceptance of the Units by the Underwriter; |
• | the Underwriter’s right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part; and |
• | other conditions contained in the Underwriting Agreement, such as the receipt by the Underwriter of officers’ certificates and legal opinions. |
Underwriter |
Per Series A Preferred Share |
Per Warrant |
Without Over- Allotment Option |
With Over- Allotment Option |
||||||||||||
Public offering price: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Underwriting discounts and commissions payable by us: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Proceeds, before expenses, to us: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
||||||||||||||||
|
|
|
|
|
|
|
|
• | a passive market maker may not effect transactions or display bids for our shares in excess of the highest independent bid price by persons who are not passive market makers; |
• | net purchases by a passive market maker on each day are generally limited to 30% of the passive market maker’s average daily trading volume in our shares during a specified two-month prior period or 200 shares, whichever is greater, and must be discontinued when that limit is reached; and |
• | passive market making bids must be identified as such. |
U.S. Securities and Exchange Commission registration fee |
$ | 5,829.97 | ||
FINRA filing fee |
9,933.59 | |||
Nasdaq listing fee |
5,000 | |||
Legal fees and expenses |
264,000 | |||
Accounting fees and expenses |
150,000 | |||
Transfer agent fees and expenses |
5,000 | |||
Printing fees and expenses |
70,000 | |||
Miscellaneous |
50,000 | |||
|
|
|||
Total |
$ | 553,933.59 | ||
|
|
Notes |
December 31, 2021 |
December 31, 2020 |
||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ | $ | ||||||||||
Trade and other receivables |
6 | |||||||||||
Current portion of prepaid expenses and other assets |
7 | |||||||||||
Current portion of long-term receivables |
6 | |||||||||||
Total current assets |
$ | $ | ||||||||||
Non-current assets |
||||||||||||
Prepaid expenses and other assets |
7 | |||||||||||
Long-term receivables |
6 | |||||||||||
Right-of-use assets |
8 | |||||||||||
Property and equipment |
9 | |||||||||||
Intangible assets |
10 | |||||||||||
Goodwill |
10 | |||||||||||
Total non-current assets |
$ | $ | ||||||||||
Total assets |
$ |
$ |
||||||||||
LIABILITIES |
||||||||||||
Current liabilities |
||||||||||||
Bank indebtedness |
13 | $ | $ | |||||||||
Trade payables and accrued liabilities |
11 | |||||||||||
Deferred revenue |
5 | |||||||||||
Current portion of loans and borrowings |
12 | |||||||||||
Current portion of convertible debentures |
14 | |||||||||||
Warrant liabilities |
15 | |||||||||||
Current portion of lease liabilities |
8 | |||||||||||
Current portion of other liabilities |
16 | |||||||||||
Current portion of business acquisition payable |
18 | |||||||||||
Total current liabilities |
$ | $ | ||||||||||
Non-current liabilities |
||||||||||||
Convertible debentures |
14 | |||||||||||
Lease liabilities |
8 | |||||||||||
Loans and borrowings |
12 | |||||||||||
Deferred income tax liabilities |
25 | |||||||||||
Other liabilities |
16 | |||||||||||
Business acquisition payable |
18 | |||||||||||
Total liabilities |
$ |
$ |
||||||||||
EQUITY |
||||||||||||
Share capital |
19 | |||||||||||
Contributed surplus |
||||||||||||
Accumulative other comprehensive income |
||||||||||||
Deficit |
( |
) | ( |
) | ||||||||
Total shareholders’ equity |
$ | $ | ||||||||||
Non-controlling interest |
21 | |||||||||||
Total equity |
$ |
$ |
||||||||||
Total liabilities and equity |
$ |
$ |
“Russ McMeekin” |
“Michael Allman” |
| ||||
Director |
Director |
Year ended December 31, |
||||||||||||||||
Notes |
2021 |
2020 |
2019 |
|||||||||||||
Revenue |
4, 5 | $ | |
$ | |
$ | |
|||||||||
Cost of sales |
( |
) | ( |
) | ( |
) | ||||||||||
Gross profit |
$ | $ | $ | |||||||||||||
Expenses |
||||||||||||||||
Salaries, wages and benefits |
||||||||||||||||
Sales and marketing |
||||||||||||||||
Research and development |
||||||||||||||||
General and administration |
||||||||||||||||
Professional and consulting fees |
||||||||||||||||
Share-based compensation |
20 | |||||||||||||||
Depreciation and amortization |
8-10 | |||||||||||||||
Total expenses |
$ | $ | $ | |||||||||||||
Operating loss |
$ | $ | $ | |||||||||||||
Other expenses (income) |
||||||||||||||||
Finance costs |
22 | |||||||||||||||
Foreign exchange loss (gain) |
( |
) | ||||||||||||||
Business acquisition costs and other expenses |
17 | |||||||||||||||
Impairment |
9,10(a) | – | – | |||||||||||||
Fair value loss on derivatives |
23 | – | – | |||||||||||||
Other income |
24 | ( |
) | ( |
) | ( |
) | |||||||||
Loss before tax |
$ | $ | $ | |||||||||||||
Current tax expense (recovery) |
25 | ( |
) | |||||||||||||
Deferred tax (recovery) expense |
25 | ( |
) | ( |
) | ( |
) | |||||||||
Net loss for the year |
$ | $ | $ | |||||||||||||
Other comprehensive (income) loss |
||||||||||||||||
Foreign subsidiary translation differences |
( |
) | ( |
) | ||||||||||||
Comprehensive loss for the year |
$ |
$ |
$ |
|||||||||||||
Net loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
||||||||||||||||
Non-controlling interest |
( |
) | ( |
) | ||||||||||||
$ |
$ |
$ |
||||||||||||||
Comprehensive loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
||||||||||||||||
Non-controlling interest |
( |
) | ( |
) | ||||||||||||
$ |
$ |
$ |
||||||||||||||
Loss per share attributable to mCloud shareholders – basic and diluted |
$ |
$ |
$ |
|||||||||||||
Weighted average number of common shares outstanding - basic and diluted |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Deficit |
Total Shareholder’s Equity |
Non- controlling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||||||
Share-based payments |
20 | – | – | – | – | – | ||||||||||||||||||||||||||||||
RSUs exercised |
20 | ( |
) | – | – | ( |
) | – | ( |
|||||||||||||||||||||||||||
Broker warrants issued |
19(b) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Shares issued in public offering, net of costs |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Warrants issued in public offering, net of costs |
19(a) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Shares issued in private placement |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued on 2021 Debentures conversion, net |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in USD public offering, net of costs |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Underwriter warrants issued in USD public offering |
19(a) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Net loss for the year |
– | – | – | – | ( |
) | ( |
) | ( |
( |
||||||||||||||||||||||||||
Other comprehensive (loss) income for the year |
– | – | – | ( |
) | – | ( |
) | ( |
|||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Deficit |
Total Shareholder’s Equity |
Non- controlling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance, December 31, 2019 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||||||
Share-based payments |
20 | – | – | – | – | – | ||||||||||||||||||||||||||||||
RSUs exercised |
20(b) | ( |
) | – | – | ( |
) | – | ( |
|||||||||||||||||||||||||||
Stock options exercised |
20(a) | ( |
) | – | – | – | ||||||||||||||||||||||||||||||
Warrants exercised |
( |
) | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in business combination - CSA |
17(d) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in business combination - kanepi |
17(e) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued for transaction costs - kanepi |
17(e) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued for asset acquisition - AirFusion |
– | – | – | – | ||||||||||||||||||||||||||||||||
Shares issued on conversion of 2019 debentures |
19(b) | – | – | – | ||||||||||||||||||||||||||||||||
Issue of special warrants, net |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Conversion of special warrants |
( |
) | – | – | – | – | – | |||||||||||||||||||||||||||||
Settlement of debt with RSUs |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in public offering, net of costs |
– | – | – | |||||||||||||||||||||||||||||||||
Net (loss) income for the year |
– | – | – | – | ( |
) | ( |
) | ( |
|||||||||||||||||||||||||||
Other comprehensive (loss) income for the year |
– | – | – | – | ( |
) | ||||||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Deficit |
Total Shareholder’s Equity |
Non- controlling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance, December 31, 2018 |
$ | |
$ | |
$ ( |
) | $ ( |
) | $ | $ | – | $ | ||||||||||||||||||||||||
Share-based payments |
20 | – | – | – | – | – | ||||||||||||||||||||||||||||||
RSUs exercised |
20(b) | ( |
) | – | – | – | – | – | ||||||||||||||||||||||||||||
Stock options exercised |
20(a) | ( |
) | – | – | – | ||||||||||||||||||||||||||||||
Share purchase warrants exercised |
18(b) | ( |
) | – | – | – | ||||||||||||||||||||||||||||||
Shares issued on business combination |
17(c) | – | – | – | – | |||||||||||||||||||||||||||||||
Transaction costs on business combination |
17(c) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued to extinguish the loan from Flow Capital |
17(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued to settle liabilities |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Share issuance costs |
– | ( |
) | – | – | ( |
) | – | ( |
|||||||||||||||||||||||||||
Warrants issued |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Equity component of convertible debentures |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Contingent shares issuable to Flow Capital |
17(a) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Non-controlling interest recognized in business combination |
– | – | – | – | – | – | ( |
) | ( |
|||||||||||||||||||||||||||
Net (loss) income for the year |
– | – | – | – | ( |
) | ( |
) | ( |
|||||||||||||||||||||||||||
Other comprehensive income for the year |
– | – | – | – | ||||||||||||||||||||||||||||||||
Balance, December 31, 2019 |
$ |
$ |
$ |
$ ( |
$ |
$ |
$ |
Year ended December 31, |
||||||||||||||||
Notes |
2021 |
2020 |
2019 |
|||||||||||||
Operating activities |
||||||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||
Items not affecting cash: |
||||||||||||||||
Depreciation and amortization |
8-10 | |||||||||||||||
Share-based compensation |
20 | |||||||||||||||
Finance costs |
22 | |||||||||||||||
Fair value loss on derivatives |
23 | – | – | |||||||||||||
Impairment |
– | – | ||||||||||||||
Other income |
24 | ( |
) | ( |
) | ( |
) | |||||||||
Provision for expected credit loss |
26 | |||||||||||||||
Unrealized foreign currency exchange gain |
( |
) | ||||||||||||||
Business acquisition costs |
– | |||||||||||||||
Current tax expense (recovery) |
25 | ( |
) | |||||||||||||
Deferred income tax recovery |
25 | ( |
) | ( |
) | ( |
) | |||||||||
Gain on settlement of lease liability |
– | – | ( |
) | ||||||||||||
Decrease in working capital |
30 | ( |
) | ( |
) | ( |
) | |||||||||
Interest paid |
( |
) | ( |
) | ( |
) | ||||||||||
Taxes paid |
– | ( |
) | ( |
) | |||||||||||
Net cash used in operating activities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||
Investing activities |
||||||||||||||||
Acquisition of property and equipment |
9 | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Acquisition of and expenditure on intangible assets |
10 | ( |
) | ( |
) | – | ||||||||||
Acquisition of royalty agreement |
17(a) | – | – | ( |
) | |||||||||||
Acquisition of assets of AirFusion |
– | ( |
) | – | ||||||||||||
Acquisition of business, net of cash acquired |
17 | – | ( |
) | ( |
) | ||||||||||
Net cash used in investing activities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||
Financing activities |
||||||||||||||||
Payment of lease liabilities |
8 | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Repayment of loans |
12 | ( |
) | ( |
) | ( |
) | |||||||||
Proceeds from loans and bank indebtedness, net of transaction costs |
12, 13 | |
|
|||||||||||||
Net (repayments) advances of bank indebtedness |
13 | ( |
) | ( |
) | |||||||||||
Proceeds from issuance of shares, net of issuance costs |
19(a) | |
– | |||||||||||||
Proceeds from issuance of convertible debentures, net of costs |
14 | |||||||||||||||
Proceeds from issuance of warrants, net of issuance costs |
19(a) | |||||||||||||||
Proceeds from the exercise of stock options, net of issuance costs |
||||||||||||||||
Proceeds from exercise of warrants, net |
– | – | ||||||||||||||
Income tax withholding on RSUs |
( |
) | ( |
) | – | |||||||||||
Net cash provided by financing activities |
$ | $ | $ | |||||||||||||
Increase in cash and cash equivalents |
$ | $ | $ | ( |
) | |||||||||||
Effect of exchange rate fluctuations on cash held |
( |
) | ( |
) | ( |
) | ||||||||||
Cash and cash equivalents, beginning of year |
||||||||||||||||
Cash and cash equivalents, end of year |
$ |
$ |
$ |
(a) |
Critical judgements in applying accounting policies |
(b) |
Key sources of estimation uncertainty |
(b) |
Key sources of estimation uncertainty (continued) |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Canada |
$ | $ | $ | |||||||||
United States |
||||||||||||
Japan |
– | |||||||||||
Australia |
– | |||||||||||
Other |
– | |||||||||||
Total revenue |
$ |
$ |
$ |
For the years ended December 31, |
2021 |
2020 |
2019 | |||
Customer A |
Less than |
n/a | ||||
Customer B |
Less than |
|||||
Customer C |
Less than |
|||||
Customer D |
Less than |
n/a |
December 31, 2021 |
December 31, 2020 |
|||||||
Canada |
$ | $ | ||||||
Australia |
||||||||
United States |
||||||||
Total non-current assets |
$ |
$ |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
AssetCare initialization 1 |
$ | $ | $ | |||||||||
AssetCare over time 2 |
||||||||||||
Engineering services 3 |
||||||||||||
$ |
$ |
$ |
1 |
Revenues from initial implementation and activation of AssetCare projects, including the sale of hardware. |
2 |
Revenues include sales of subscriptions to AssetCare, other subscriptions, post contract support and maintenance, perpetual software licenses, and installation and engineering services. |
3 |
Revenues includes consulting, implementation and integration services entered into on a time and materials basis or fixed fee basis without the use of AssetCare. |
Year ended December 31, |
||||||||||||
Timing of revenue recognition | 2021 |
2020 |
2019 |
|||||||||
Over time |
$ | $ | $ | |||||||||
At a point in time upon completion |
||||||||||||
$ |
$ |
$ |
Unbilled revenue |
Deferred revenue |
|||||||||
Balance at January 1, 2019 |
$ |
— |
$ |
|||||||
Acquired in business combination (Note 17(c)) |
||||||||||
Acquired in business combination (Note 17(b)) |
— |
|||||||||
Additions |
||||||||||
Less: transferred to trade and other receivables |
( |
) |
— |
|||||||
Less: recognized in revenue |
— |
( |
) | |||||||
Less: Loss allowance |
( |
) |
— |
|||||||
Effect of movement in exchange rates |
— |
( |
) | |||||||
Balance at December 31, 2019 |
$ | $ | ||||||||
Acquired in business combination |
– | |||||||||
Additions |
||||||||||
Less: transferred to trade and other receivables |
( |
) | – | |||||||
Less: write-offs |
( |
) | – | |||||||
Less: recognized in revenue |
– | ( |
) | |||||||
Less: applied to outstanding trade receivables |
– | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | ||||||||
Balance at December 31, 2020 |
$ |
$ |
||||||||
Additions |
|
|||||||||
Less: transferred to trade and other receivables |
( |
) | – | |||||||
Less: recognized in revenue |
– | ( |
) | |||||||
Effect of movement in exchange rates |
– | |||||||||
Balance at December 31, 2021 1 |
$ |
$ |
1 |
Unbilled revenue is included in trade and other receivables (Note 6) and relates to the Company’s right to consideration for work completed but not billed at the reporting date. Unbilled revenue is transferred to trade and other receivables when services are billed to customers. |
December 31, 2021 |
December 31, 2020 |
|||||||
Trade receivables from contracts with customers |
$ | $ | ||||||
Unbilled revenue (Note 5) |
||||||||
Indirect taxes receivable |
||||||||
Income taxes receivable |
||||||||
Other receivables |
||||||||
Contract asset 1 |
||||||||
Loss allowance (Note 26(b)) |
( |
) | ( |
) | ||||
Total trade and other receivables - current |
$ |
$ |
1 |
At December 31, 2021, the total contract assets were $ |
December 31, 2021 |
December 31, 2020 |
|||||||
Current portion of long-term receivables 1 |
$ | $ | ||||||
Non-current portion of long-term receivables 2 |
||||||||
Total long-term receivables |
$ |
$ |
1 |
Net of expected credit loss allowance of $ $ |
2 |
Net of expected credit loss allowance of $ |
December 31, 2021 |
December 31, 2020 |
|||||||
Prepaid insurance |
$ | $ | ||||||
Advances |
||||||||
Deposits |
||||||||
Prepaid licenses |
||||||||
Prepaid services |
||||||||
Other prepaid costs |
||||||||
Other assets |
||||||||
Prepaid expenses and other assets |
$ |
$ |
||||||
Current portion |
$ |
$ |
||||||
Non-current portion |
||||||||
$ |
$ |
Office |
Equipment and Vehicles |
Total |
||||||||||
Balance at January 1, 2019 |
$ | $ | – | $ | ||||||||
Acquired right-of-use assets (Note 17) |
||||||||||||
Additions to right-of-use assets |
– | |||||||||||
Depreciation charge for the year |
( |
) | ( |
) | ( |
) | ||||||
Impairment charge for the year |
( |
) | – | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | – | ( |
) | |||||||
Balance at January 1, 2020 |
$ |
$ |
$ |
|||||||||
Acquired right-of-use assets (Note 17) |
– | |||||||||||
Additions to right-of-use assets |
||||||||||||
Depreciation charge for the year |
( |
) | ( |
) | ( |
) | ||||||
Impact of lease modification |
( |
) | – | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | ||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
|||||||||
Depreciation charge for the year |
( |
) | ( |
) | ( |
) | ||||||
Impact of lease modification |
( |
) | – | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | ||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Accretion of lease liabilities included in finance costs |
$ | $ | $ | |||||||||
Depreciation of right-of-use assets 1 |
||||||||||||
Expense related to variable lease payments 2 |
– | |||||||||||
Expense related to short-term leases 2 |
– | – | ||||||||||
$ |
$ |
$ |
1 |
Included in depreciation and amortization expense. |
2 |
Included in rent expense within general and administrative expense. |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Total cash outflows included in operating activities |
$ | $ | $ | |||||||||
Total cash outflows included in financing activities |
$ | |
$ | |
$ | |
Office Furniture and Equipment |
Leasehold Improvements |
Computer Equipment |
Total |
|||||||||||||||||||
Cost: |
||||||||||||||||||||||
At January 1, 2019 |
$ | $ | $ | $ | ||||||||||||||||||
Additions |
||||||||||||||||||||||
Acquisitions |
||||||||||||||||||||||
Impairment |
– | – | ( |
) | ( |
) | ||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
At December 31, 2019 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Additions |
– | |||||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Additions |
– | – | ||||||||||||||||||||
Disposals |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Accumulated depreciation: |
||||||||||||||||||||||
At January 1, 2019 |
$ | $ | $ | $ | ||||||||||||||||||
Depreciation |
||||||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
At December 31, 2019 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Depreciation |
||||||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Depreciation |
||||||||||||||||||||||
Disposals |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Other movements |
– | ( |
) | – | ||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Carrying amounts: |
||||||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ||||||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
Patents and trademarks |
Customer relationships |
Technology |
Total |
|||||||||||||
Cost: |
||||||||||||||||
At January 1, 2019 |
$ | |
$ | $ | $ | |||||||||||
Additions |
– | – | – | – | ||||||||||||
Acquisitions |
– | |||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2019 |
$ |
$ |
$ |
$ |
||||||||||||
Additions |
– | – | ||||||||||||||
Acquisitions |
– | |||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||
Additions |
– | – | ||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||
Accumulated amortization and impairments: |
||||||||||||||||
At January 1, 2019 |
$ | $ | $ | $ | ||||||||||||
Amortization 1 |
||||||||||||||||
Impairment |
– | – | ||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2019 |
$ | $ | $ | $ | ||||||||||||
Amortization 1 |
||||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||
Amortization 1 |
||||||||||||||||
Effect of movement in exchange rates |
||||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||
Carrying amounts: |
||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ||||||||||||
Balance at December 31, 2021 |
$ | $ | $ | $ |
1 |
Amortization charges are included in depreciation and amortization in the consolidated statements of loss and comprehensive loss. |
December 31, 2021 |
December 31, 2020 |
|||||||
Opening balance |
$ | |
$ | |||||
Acquisitions, business combinations (Note 18) |
– | |||||||
Effect of movements in exchange rates |
( |
( |
||||||
Total goodwill |
$ |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Trade payables |
$ | $ | ||||||
Accrued liabilities |
||||||||
Interest payable |
||||||||
Mastercard facility (Note 13) |
||||||||
Due to related parties (Note 28) |
||||||||
Income taxes payable |
||||||||
Indirect taxes payable |
||||||||
Other |
||||||||
Total trade payables and accrued liabilities |
$ |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Term loan |
$ | $ | ||||||
Nations Interbanc facility |
||||||||
Debenture payable to Industry Canada |
||||||||
Loan payable to related party 1 |
||||||||
Oracle financing 2 |
||||||||
Other loans and financing |
||||||||
Total 3 |
$ |
$ |
||||||
Current |
||||||||
Non-current |
||||||||
$ |
$ |
1 |
Loan assumed as part of CSA Acquisition (Note 17(d)) which bears interest at |
2 |
Financing arrangements provided by Oracle Credit Corporation (“Oracle”) bearing interest between |
3 |
Note 30(b) includes the reconciliation of movements of liabilities to cash flows arising from financing activities. |
December 31, 2021 |
December 31, 2020 |
|||||||
ATB Financial revolving operating facility |
$ | |
$ | – | ||||
Operating loan facility 1 |
– | |||||||
Bank overdraft 1 |
– | |||||||
Total |
$ |
$ |
1 |
At December 31, 2020, the Company had access to an operating loan facility and Mastercard facility. On April 15, 2021, the operating loan facility was repaid and closed. The Mastercard facility remains in place and at December 31, 2021, $ |
December 31, 2021 |
December 31, 2020 |
|||||||
2019 Convertible debentures liability (a) |
$ | $ | |
|||||
2021 Convertible debentures liability (b) |
– | |||||||
2021 Convertible debentures embedded derivative (b) |
– | |||||||
Total |
$ |
$ |
Current debentures |
$ | |
$ | – | ||||
Non-current debentures |
||||||||
$ |
$ |
a) |
2019 Convertible debentures |
December 31, 2021 |
December 31, 2020 |
|||||||
Opening balance |
$ | |
$ | |
||||
Conversion of debentures into common shares |
– | ( |
||||||
Interest paid |
( |
( |
||||||
Accreted interest at effective interest rate |
||||||||
Carrying amount of liability component |
$ | $ | ||||||
Less: interest payable |
( |
( |
||||||
Total |
$ |
$ |
a) |
2019 Convertible debentures (continued) |
b) |
2021 Convertible debentures |
b) |
2021 Convertible debentures (continued) |
December 31, 2021 |
||||
Proceeds from issue of convertible debentures |
$ | |
||
Fair value adjustments (Note 23) |
||||
Total fair value of convertible debentures |
||||
Less: fair value of embedded derivative |
( |
) | ||
Less: transaction costs 1 |
( |
) | ||
Carrying value of liability at inception |
||||
Interest expense associated with liability |
||||
Debt extinguishment, including interest payable |
( |
) | ||
Foreign exchange adjustments |
( |
) | ||
Less: accrued interest included in accrued liabilities |
( |
) | ||
Carrying value of liability at end of period 2 |
$ |
1 |
Total transaction costs were $ |
2 |
Convertible debt in the principal amount of US$ |
December 31, 2021 |
||||
Fair value of embedded derivative at inception |
$ | |
||
Fair value decrease 1 |
( |
) | ||
Derecognition of embedded derivative on conversion |
( |
) | ||
Foreign exchange adjustments |
( |
) | ||
Balance, embedded derivative |
$ |
1 |
The fair value of the embedded derivative is remeasured at the end of each reporting period and on conversion and recognized in fair value (gain) loss on derivatives in the consolidated statements of loss and comprehensive loss (Note 23). |
December 31, 2021 |
December 31, 2020 |
|||||||
Derivative warrant liabilities - 2021 Debentures (a) |
$ | |
$ | – | ||||
Derivative warrant liabilities - USD equity financing (b) |
– | |||||||
Warrant liability related to business acquisition (c) |
||||||||
Other warrant liability (c) |
– | |||||||
Total, all current |
$ |
$ |
Derivative |
warrant liabilities |
December 31, 2021 |
August 13, 2021 |
|||||||
Share price at date of valuation |
$ | |
$ | |
||||
Exercise price |
$ | $ | ||||||
Risk free rate |
||||||||
Expected life (years) |
||||||||
Expected volatility 1 |
||||||||
Fair value per warrant 2 |
$ | $ |
1 |
Expected volatility at December 31, 2021 measured at implied volatility of traded warrants. |
2 |
Considers a liquidity discount of |
December 31, 2021 |
November 29, 2021 |
|||||||
Share price at date of valuation |
$ | |
$ | |
||||
Exercise price |
$ | $ | ||||||
Risk free rate |
||||||||
Expected life (years) |
||||||||
Expected volatility 1 |
||||||||
Fair value per warrant |
$ | $ |
1 |
Expected volatility at represents implied volatility of the Company’s traded warrants. |
|
c) |
Other warrant liabilities |
December 31, 2021 |
December 31, 2020 |
|||||||
US Government loans |
$ | – | $ | |||||
2021 Debentures subscriptions payable (Note 14(b)) |
– | |||||||
Total |
$ |
– |
$ |
|||||
Current portion 1 |
$ | – | ||||||
Non-current portion |
– | |||||||
$ |
– |
$ |
1 |
Includes US Government loans of $ |
a) |
Acquisition of Royalty interests |
i. | a receivable owing by Agnity to Flow of USD $ |
ii. | a monthly royalty payment stream until October 31, 2020 equal to the greater of: |
• | A monthly amount of USD $ |
• | |
iii. | commencing November 1, 2020, a monthly royalty payment stream equal to 4.25% of Agnity’s revenue for each calendar month in perpetuity. |
(i) | A secured loan agreement for USD $ |
• | Cash of USD $ |
• | Issue |
Share price |
$ | |
Risk free rate |
||
Expected life |
||
Expected volatility |
||
Expected dividends |
a) |
Acquisition of Royalty interests (continued) |
(i) | The Company also agreed to issue a quantity of its common shares based on the trading price of the Company. Specifically, for the period after January 22, 2019 and prior to January 22, 2025, if the five-day volume weighted average trading price of the Company’s common shares equals or exceeds: |
• | $ |
• | $ |
• | $ |
Barrier share price |
$ | |
Risk free rate |
||
Expected life |
||
Expected volatility |
||
Expected dividends |
b) |
Acquisition of Agnity |
b) |
Acquisition of Agnity (continued) |
Consideration transferred: |
Final |
|||
Change in fair-value of interest in Royalty Agreement (i) |
$ | |||
Assumption of Agnity’s liabilities |
||||
Total consideration transferred |
$ |
(i) |
The fair value of interest in the Royalty Agreement at April 22, 2019 was estimated using the discounted cash flow model. The major inputs employed in the model include forecasted royalty payments and the discount rate of |
Fair value of assets and liabilities recognized: |
Final |
|||
Cash and cash equivalents |
$ | |||
Trade and other receivables |
||||
Prepaid expenses and deposits |
||||
Long term receivable |
– | |||
Property and equipment |
||||
Intangible Asset – Technology |
||||
Intangible Asset – Customer Relationship |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Deferred revenue |
( |
) | ||
Loans and borrowings |
( |
) | ||
Warrant liability (i) |
( |
) | ||
Due to related party |
( |
) | ||
Deferred income tax liability |
( |
) | ||
Net identifiable assets acquired (liabilities assumed) |
( |
) | ||
Allocation to non-controlling interest |
$ |
(i) | A warrant was issued by Agnity in 2015 which entitles the warrant holder to acquire |
b) |
Acquisition of Agnity (continued) |
c) |
Acquisition of mCloud Technologies Services Inc. |
Consideration transferred: |
Final |
|||
Cash consideration |
$ | |||
Fair value of demand promissory notes issued (1) |
||||
Fair value of common shares transferred (2) |
||||
Total consideration transferred |
$ |
c) |
Acquisition of mCloud Technologies Services Inc. (continued) |
Fair value of assets and liabilities recognized: |
Final |
|||
Cash and cash equivalents |
$ | |||
Trade and other receivables (includes Unbilled revenue of $ |
||||
Prepaid expenses and deposits |
||||
Right-of-use assets |
||||
Property and equipment |
||||
Intangible asset – Customer relationships |
||||
Intangible asset – Technology |
||||
Accounts payable and accrued liabilities |
( |
|||
Deferred revenue |
( |
) | ||
Lease liabilities |
( |
) | ||
Deferred income tax liability |
( |
) | ||
Fair value of net assets acquired |
||||
Goodwill |
$ |
|||
$ |
d) |
Acquisition of Construction Systems Associates, Inc. USA |
Final |
||||
Consideration transferred: |
||||
Cash consideration |
$ | |||
Fair value of common share consideration |
||||
Fair value of contingent consideration payable |
||||
Total consideration |
$ |
Fair value of assets and liabilities recognized: |
||||
Cash |
$ | |||
Trade and other receivables |
||||
Prepaid expenses and other deposits |
||||
Property and equipment |
||||
Right of use assets |
||||
Intangible - technology |
||||
Intangible - customer relationships |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Short-term loan |
( |
) | ||
Lease liabilities |
( |
) | ||
Deferred tax liabilities |
||||
Fair value of net assets acquired |
$ |
|||
Goodwill |
$ |
e) |
Acquisition of kanepi |
Final |
||||
Consideration transferred: |
||||
Cash consideration |
$ | |||
Fair value of common share consideration |
||||
Fair value of contingent consideration payable |
||||
Total consideration |
$ |
Fair value of assets and liabilities recognized: |
||||
Cash |
$ | |||
Trade and other receivables |
||||
Other current assets |
||||
Property and equipment |
||||
Right of use assets |
||||
Intangible - technology |
||||
Intangible - customer relationships |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Lease liabilities |
( |
) | ||
Deferred tax liabilities |
( |
) | ||
Fair value of net assets acquired |
$ |
|||
Goodwill |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Opening balance |
$ | $ | ||||||
Contingent consideration changes related to CSA (Note 17) |
( |
) | ||||||
Contingent consideration changes related to kanepi (Note 17) |
( |
) | ||||||
Effect of foreign exchange differences |
( |
) | ( |
) | ||||
Current portion |
||||||||
Non-current portion |
||||||||
$ |
$ |
a) |
Common shares |
b) Warrants |
Number of Warrants |
Weighted Average Exercise Price $ | |||||
December 31, 2018 |
$ | |||||
Issued |
$ | |||||
Exercised |
( |
$ | ||||
Expired |
( |
|||||
December 31, 2019 |
$ | |||||
Issued |
||||||
Exercised |
( |
|||||
Expired |
( |
|||||
December 31, 2020 |
$ | |||||
Issued |
||||||
Expired |
( |
|||||
December 31, 2021 |
$ |
• |
• |
• |
• |
• |
• |
Expiry Date |
Exercise Price $ |
Outstanding Warrants | ||||
June 2022 |
||||||
July 2022 |
||||||
December 2022 |
||||||
January 2023 |
||||||
January 2023 |
||||||
February 2023 |
||||||
March 2023 |
||||||
May 2023 |
||||||
April 2024 |
||||||
June 2024 |
||||||
August 2024 |
||||||
January 2025 |
||||||
May 2025 |
||||||
July 2025 |
||||||
November 2026 |
||||||
$ |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Stock options (a) |
$ | $ | $ | |||||||||
Restricted share units (b) |
||||||||||||
Total |
$ |
$ |
$ |
a) |
Stock Options |
Number of Options |
Weighted Average Exercise Price |
Number of Options |
Weighted Average Exercise Price |
Number of Options |
Weighted Average Exercise Price |
|||||||||||||||||||
2021 |
2021 |
2020 |
2020 |
2019 |
2019 |
|||||||||||||||||||
Opening balance |
$ | $ | $ | |||||||||||||||||||||
Granted |
||||||||||||||||||||||||
Exercised |
– | – | ( |
) | ( |
) | ||||||||||||||||||
Forfeited |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Expired |
( |
) | ( |
) | – | – | ||||||||||||||||||
Cancelled |
– | – | ( |
) | – | – | ||||||||||||||||||
Outstanding at December 31 |
$ |
$ |
$ |
|||||||||||||||||||||
Exercisable at December 31 |
$ |
$ |
$ |
a) |
Stock Options (continued) |
Options Outstanding |
Options exercisable | |||||||||||||||||||||||
Range of prices |
Number |
Weighted average exercise price |
Weighted average life (years) |
Number |
Weighted average exercise price |
|||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||
$ |
$ | |
$ | |||||||||||||||||||||
$ |
$ | $ | |
|||||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||
$ |
$ |
2021 |
2020 |
2019 | ||||
Grant date share price |
$ |
$ |
$ | |||
Exercise price |
$ |
$ |
$ | |||
Risk-free rate |
||||||
Expected life, years |
||||||
Expected volatility |
||||||
Expected dividends |
– % | – % | – % | |||
Forfeiture rate |
– % |
b) |
Restricted Share Units (“RSUs”) |
b) |
Restricted Share Units (“RSUs”) (continued) |
Number of RSUs |
2021 |
2020 |
2019 |
|||||||||
Outstanding at January 1 |
||||||||||||
Granted |
||||||||||||
Exercised 1 |
( |
( |
( |
|||||||||
Forfeited |
( |
( |
( |
|||||||||
Withheld 1 |
( |
( |
– | |||||||||
Outstanding at December 31 |
||||||||||||
Exercisable at December 31 |
1 |
December 31, 2021 |
December 31, 2020 |
|||||||||||
NCI percentage |
||||||||||||
Current assets |
$ | $ | ||||||||||
Non-current assets |
||||||||||||
Current liabilities |
( |
( |
||||||||||
Non-current liabilities |
( |
( |
||||||||||
Net assets attributable to NCI |
$ | $ | ||||||||||
For the years ended |
December 31, 2021 |
December 31, 2020 |
December 31, 20 19 |
|||||||||
Revenue |
$ | $ | $ | |||||||||
Income (loss) allocated to NCI |
( |
|||||||||||
Other comprehensive income allocated to NCI |
( |
|||||||||||
Total comprehensive (loss) income attributable to NCI |
$ | ( |
$ | $ | ||||||||
Cash flows (used in) provided by operating activities |
$ | ( |
( |
|||||||||
Cash flows used in investing activities |
( |
– | ( |
|||||||||
Cash flows (used in) provided by financing activities |
( |
|||||||||||
Foreign exchange impact on cash held in USD |
( |
|||||||||||
Net (decrease) increase in cash and cash equivalents |
$ | ( |
$ | $ |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Interest on loans and borrowings (Note 12) |
$ | |
$ | $ | ||||||||
Interest on convertible debentures (Note 14) |
||||||||||||
Interest on lease liabilities (Note 8) |
||||||||||||
Transaction costs expensed 1 |
– | – | ||||||||||
Other finance costs |
– | – | ||||||||||
Total finance costs |
$ |
$ |
$ |
1 |
Transaction costs include costs incurred associated with financing or equity transactions that are not otherwise netted against the debt or equity instrument. The majority of costs are associated with the USD brokered public offering (Note 19(a)), the 2021 Debentures (Note 14(b)), the Fiera term loan amendment (Note 12) and the ATB facility amendment (Note 13). |
Year Ended December 31, |
2021 |
||||
Gain on embedded derivatives 1 |
$ | ( |
) | |
Deferred charge loss 1 |
||||
Loss on substantial modification and conversion 1 |
||||
Gain on warrant liability remeasurement (Note 15) 2 |
( |
) | ||
Total |
$ |
1 |
Associated with the 2021 Debentures (Note 14(b)) of which the majority is realized at December 31, 2021. |
2 |
Change in fair value unrealized (Note 26). |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Government assistance 1 |
$ | ( |
$ | ( |
$ | – | ||||||
US Government loan forgiveness 2 (Note 16) |
( |
( |
– | |||||||||
Derecognition of contingent consideration (Note 18) |
( |
– | – | |||||||||
Other |
( |
( |
( |
|||||||||
Total other income |
$ |
( |
$ |
( |
$ |
( |
1 |
Majority represents amounts received from the Canadian Government for wage and rental subsidies associated with COVID-19. The amount of government assistance available is dependent on the programs in place and the Company’s eligibility for these programs. |
2 |
Includes other income recognized as below market interest rate benefit. |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Current tax expense |
||||||||||||
Current year |
( |
) | ||||||||||
Changes in estimates related to prior years |
– | – | – | |||||||||
( |
||||||||||||
Deferred tax expense (recovery) |
||||||||||||
Origination and reversal of temporary differences |
( |
) | ( |
) | ( |
) | ||||||
Change in unrecognized deferred income tax assets |
||||||||||||
( |
( |
( |
||||||||||
Tax expense (recovery) |
$ |
( |
$ |
( |
$ |
( |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Loss before taxes |
$ | ( |
$ | ( |
$ | ( |
||||||
Statutory income tax rate 1 |
% | % | % | |||||||||
Income tax recovery at statutory rate |
( |
( |
( |
|||||||||
Increase (decrease) in taxes resulting from: |
||||||||||||
Change in deferred tax assets not recognized |
||||||||||||
Foreign tax rate and other foreign tax differences |
( |
( |
( |
|||||||||
Change in enacted rates |
( |
– | ||||||||||
Share issuance costs and other |
( |
|||||||||||
Non-deductible transaction costs |
||||||||||||
Other non-deductible items |
||||||||||||
Tax expense (recovery) |
$ |
( |
$ |
( |
$ |
( |
1 |
Comprised of the Canadian Federal effective corporate tax rate of |
At December 31, 2020 |
Recovery/ (expense) through earnings |
Recovery/ (expense) through equity |
Recovery/ (expense) through OCI |
At December 31, 2021 |
||||||||||||||||||
Property and equipment |
$ | $ | ( |
$ | – | $ | $ | |||||||||||||||
Intangible assets |
( |
– | ( |
|||||||||||||||||||
Loans and accrued liabilities |
( |
– | ( |
( |
||||||||||||||||||
Share issuance costs |
– | – | ||||||||||||||||||||
Foreign exchange |
– | ( |
– | ( |
||||||||||||||||||
Non-capital losses/net operating losses |
( |
– | ( |
|||||||||||||||||||
Total |
$ |
( |
$ |
$ |
– |
$ |
$ |
( |
At December 31, 2019 |
Acquired in business combinations |
Recovery/ (expense) through earnings |
Recovery/ (expense) through equity |
Recovery/ (expense) through OCI |
At December 31, 2020 |
|||||||||||||||||||
Property and equipment |
$ | – | $ | ( |
$ | $ | – | $ | ( |
$ | ||||||||||||||
Intangible assets |
( |
( |
– | ( |
||||||||||||||||||||
Loans and accrued liabilities |
( |
– | ( |
( |
( |
|||||||||||||||||||
Share issuance costs |
– | – | – | – | ||||||||||||||||||||
Foreign exchange |
( |
– | – | – | ||||||||||||||||||||
Non-capital losses/net operating losses |
– | ( |
– | ( |
||||||||||||||||||||
Total |
$ |
( |
$ |
( |
$ |
$ |
$ |
$ |
( |
d) |
Deferred tax assets not recognized and tax losses carried forward |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Net operating losses - United States |
$ | $ | ||||||
Non-capital losses - Canada |
||||||||
Foreign tax losses |
||||||||
Investment tax credits and research and development expenditures |
||||||||
Property and equipment |
||||||||
Share issuance costs |
||||||||
Other |
||||||||
$ |
$ |
a) |
Classification and measurement of financial assets and liabilities by category |
Financial assets |
Measurement basis |
December 31, 2021 |
December 31, 2020 |
|||||||
Cash and cash equivalents |
Amortized cost | $ | $ | |||||||
Trade and other receivables 1 |
Amortized cost | |||||||||
Long-term receivables |
Amortized cost | |||||||||
Derivative asset |
FVTPL | |||||||||
$ |
$ |
|||||||||
Financial liabilities |
||||||||||
Bank indebtedness |
Amortized cost | $ | $ | |||||||
Trade payables and accrued liabilities 1 |
Amortized cost | |||||||||
Loans and borrowings |
Amortized cost | |||||||||
Lease liabilities 2 |
Amortized cost | |||||||||
2019 Debentures - host liability 3 |
Amortized cost | |||||||||
2021 Debentures - host liability 3 |
Amortized cost | |||||||||
2021 Debentures embedded derivative |
FVTPL | |||||||||
Warrant liability - business acquisition |
FVTPL | |||||||||
Warrant liabilities - derivatives (Note 15) |
FVTPL | |||||||||
Business acquisition payable |
Amortized cost | |||||||||
Other liabilities |
Amortized cost | |||||||||
$ |
$ |
1 |
Excludes amounts for indirect taxes, income taxes and contract asset, where applicable. Note 27 describes credit risk associated with trade receivables including reconciliation of expected credit loss allowance. |
2 |
Lease liabilities are not subject to classification in the fair value hierarchy. |
3 |
2019 Debentures (Note 14(a)) and 2021 Debentures host liability (Note 14(b)). |
b) |
Measurement of fair value |
b) |
Measurement of fair value (continued) |
b) |
Measurement of fair value (continued) |
a) |
Liquidity risk (continued) |
At December 31, 2021 |
Undiscounted Contractual Cash Flows |
|||||||||||||||||||
Carrying Amount |
< 1 year |
1 – 2 years |
> 2 years |
Total |
||||||||||||||||
Bank indebtedness 1 |
$ | $ | $ | – | $ | – | $ | |||||||||||||
Trade payables and accrued liabilities |
– | – | ||||||||||||||||||
Loans and borrowings 2 |
– | |||||||||||||||||||
Lease liabilities 3 |
||||||||||||||||||||
2019 Debentures |
– | – | ||||||||||||||||||
2021 Debentures |
– | |||||||||||||||||||
Warrant liabilities 4 |
– | – | ||||||||||||||||||
Business acquisition payable |
– | – | ||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
1 |
No contractual maturity. Excludes interest charged on facility as detailed in Note 13. |
2 |
Includes term loan with a carrying value of $ |
3 |
Variable costs due under leases not included in this amount. Minimum payment related to leases which have not yet commenced are not included in this amount. See Note 29. |
4 |
Majority of liability will be settled by issuing common shares of the Company when warrants are exercised during the year. The remaining amount may be settled in cash or common shares of Agnity (Note 15). |
As at December 31, 2020 |
Undiscounted Contractual Cash Flows |
|||||||||||||||||||
Carrying Amount |
< 1 year |
1 – 2 years |
> 2 years |
Total |
||||||||||||||||
Bank indebtedness |
$ | $ | $ | – | $ | – | $ | |||||||||||||
Trade payables and accrued liabilities |
– | – | ||||||||||||||||||
Loans and borrowings |
||||||||||||||||||||
Lease liabilities |
||||||||||||||||||||
2019 Debentures |
– | |||||||||||||||||||
Warrant liabilities |
– | – | ||||||||||||||||||
Business acquisition payable |
– | |||||||||||||||||||
Other liabilities |
– | |||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
b) |
Credit risk |
b) |
Credit risk (continued) |
December 31, 2021 |
December 31, 2020 |
|||||||
Beginning balance |
$ | $ | ||||||
Increase in loss allowance |
||||||||
Amounts written off during the year as uncollectible |
( |
) | ( |
) | ||||
Effects of movement in exchange rates |
– | |||||||
Total |
$ |
$ |
c) |
Market risk |
For the years ended December 31, |
2021 |
2020 |
2019 |
|||||||||
Salaries, management and directors’ fees |
$ | $ | $ | |||||||||
Share-based payments |
||||||||||||
Total |
$ |
$ |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Due to principal owner of Agnity 2 |
$ | $ | ||||||
Due to officer of Company for working capital loan 2 |
||||||||
Due to key management personnel 2 |
||||||||
Due to Agnity Communications Private Ltd. 3 |
||||||||
Loan due to former shareholder of CSA 4 |
||||||||
Amount due to related parties |
$ |
$ |
1 |
Unless otherwise noted, all amounts due are unsecured, non-interest bearing and due on demand. |
2 |
Included in trade accounts payable and accrued liabilities on the consolidated statements of financial position. |
3 |
Associated with consulting services paid to a company partially owned by the principal owner of Agnity. Consulting services were $ ; December 31, 2019 - $ Balance due included in trade accounts payable and accrued liabilities on the consolidated statements of financial position. |
4 |
Included in loans and borrowings (Note 12) on the consolidated statements of financial position. |
Undiscounted Contractual Cash Flows |
||||||||||||||||||||
< 1 year |
2 - 3 years |
4 - 5 years |
More than 5 years |
Total |
||||||||||||||||
Variable lease payments 1 |
$ | $ | $ | $ | $ | |||||||||||||||
Lease payments related to leases which have not yet commenced 2 |
||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
1 |
Variable lease payments associated lease liabilities (Note 8). |
2 |
In October 2021, the Company executed a |
2021 |
2020 |
2019 |
||||||||||
Trade and other receivables ( increase) |
$ ( |
$ ( |
$ ( |
|||||||||
Long-term receivables decrease (increase) |
( |
( |
||||||||||
Prepaid expenses and other assets decrease ( increase) |
( |
( |
||||||||||
Trade payables and accrued liabilities (decrease) increase |
( |
|||||||||||
Deferred revenue increase |
||||||||||||
Decrease in working capital |
$ ( |
$ ( |
$ ( |
2021 |
2020 |
2019 |
||||||||||
Balance of loans, borrowings and PPP loans, beginning of year |
$ |
$ |
$ |
|||||||||
New advances |
||||||||||||
Repayments of principal |
( |
( |
( |
|||||||||
Repayments of interest |
( |
( |
( |
|||||||||
Liability assumed |
– | – | ||||||||||
Liability related items |
||||||||||||
Assumption of loans in business combination |
– | |||||||||||
Forgiveness of PPP Loans |
( |
( |
– | |||||||||
Finance fees paid |
( |
– | ||||||||||
Non-cash related items |
||||||||||||
Accretion of interest and debt issuance costs |
||||||||||||
Loss on debt modification |
– | – | ||||||||||
Foreign exchange and other |
( |
( |
||||||||||
Balance of loans, borrowings and PPP loans, end of year |
$ |
$ |
$ |
For the years ended December 31, |
2021 |
2020 |
2019 |
|||||||||||||
Value of shares issued in business combination |
$ | – | $ | |
$ | |
||||||||||
Value of shares issued on conversion of 2021 Debentures |
14(b) | $ | |
$ | – | $ | – | |||||||||
Value of share issued on conversion of 2019 Debentures |
$ | – | $ | $ | – | |||||||||||
Value of shares issued on AirFusion asset acquisition |
$ | – | $ | $ | – | |||||||||||
Settlement of liabilities through issuance of common shares or RSUs |
$ | – | $ | $ | ||||||||||||
Non-cash accretion of interest included in finance cost |
$ | $ | $ | |||||||||||||
Non-cash broker warrants compensation |
19 (b) |
$ | $ | – | $ | – | ||||||||||
Non-cash underwriter warrants compensation |
1 9 (b) |
$ | $ | – | $ | – | ||||||||||
Non-cash warrants consideration associated with credit facility |
$ | $ | – | $ | – | |||||||||||
Shares issued to extinguish the loan from Flow Capital |
$ | – | $ | – | $ | |||||||||||
Addition to right-of-use assets |
$ | – | $ | $ | ||||||||||||
Addition to lease liabilities |
$ | – | $ | $ |
Principle activity |
Place of business and operations |
Functional currency |
||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
A. |
Basis of Consolidation (continued) |
B. |
Foreign currency |
C. |
Revenue recognition |
D. |
Financial Instruments |
i. |
Recognition and initial measurement |
ii. |
Classification and subsequent measurement |
• | it is held within a business model whose objective is to hold assets to collect contractual cash flows; and |
• | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
• | it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and |
• | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
iii. |
Derecognition of financial assets and liabilities |
iv. |
Impairment of non-derivative financial assets |
iv. |
Impairment of non-derivative financial assets (continued) |
E. |
Property and equipment |
Life | ||
Computer equipment |
||
Office furniture and equipment |
||
Leasehold improvements |
F. |
Intangible assets and goodwill |
Life | ||
Patents and trademarks |
||
Customer relationships |
||
Technology |
F. |
Intangible assets and goodwill (continued) |
• | Technical feasibility of completing the intangible asset results in the intangible asset being available for use or sale; |
• | There is an intention to complete the intangible asset and use or sell it; |
• | There is an ability to use or sell the intangible asset; |
• | Evidence to suggest how the intangible asset will generate probable future economic benefits; |
• | There is availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and, |
• | An ability to reliably measure the expenditure(s) attributable to the intangible asset during its development exists. |
G. |
Impairment of non-financial assets |
G. |
Impairment of non-financial assets (continued) |
H. |
Leases |
i. |
Recognition and initial measurement as a lessee |
• | fixed payments (including in-substance fixed payments), less any lease incentives receivable; |
• | variable lease payments that depend on an index or a rate (such as CPI), initially measured using the index or rate as at the commencement date; |
• | amounts expected to be payable by the Company under residual value guarantees; |
• | exercise price of a purchase option if the Company is reasonably certain to exercise that option; and |
• | payments of penalties for terminating the lease, if the lease term reflects the Company exercising an option to terminate the lease. |
ii. |
Classification and subsequent measurement as a lessee |
H. |
Leases (continued) |
I. |
Government grants |
J. |
Provisions |
K. |
Share related items |
K. |
Share related items (continued) |
L. |
Fair value measurement |
• | Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date; |
• | Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and |
• | Level 3 inputs are unobservable inputs for the asset or liability. |
M. |
Convertible debentures |
M. |
Convertible debentures (continued) |
N. |
Warrant liabilities |
O. |
Income taxes and deferred taxation |
P. |
Accounting standards development |
Notes |
March 31, 2022 |
December 31, 2021 |
||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ |
$ |
||||||||||
Trade and other receivables |
5 |
|||||||||||
Current portion of prepaid expenses and other assets |
||||||||||||
Current portion of long-term receivables |
5 |
|||||||||||
Total current assets |
$ |
$ |
||||||||||
Non-current assets |
||||||||||||
Prepaid expenses and other assets |
$ |
$ |
||||||||||
Long-term receivables |
5 |
|||||||||||
Right-of-use assets |
6 |
|||||||||||
Property and equipment |
||||||||||||
Intangible assets |
||||||||||||
Goodwill |
||||||||||||
Total non-current assets |
$ |
$ |
||||||||||
Total assets |
$ |
$ |
||||||||||
LIABILITIES |
||||||||||||
Current liabilities |
||||||||||||
Bank indebtedness |
9 |
$ |
$ |
|||||||||
Trade payables and accrued liabilities |
7 |
|||||||||||
Deferred revenue |
4 |
|||||||||||
Current portion of loans and borrowings |
8 |
|||||||||||
Current portion of convertible debentures |
10 |
(a) |
||||||||||
Warrant liabilities |
11 |
|||||||||||
Current portion of lease liabilities |
6 |
|||||||||||
Business acquisition payable |
||||||||||||
Total current liabilities |
$ |
$ |
||||||||||
Non-current liabilities |
||||||||||||
Convertible debentures |
10 |
(b) |
$ |
$ |
||||||||
Lease liabilities |
6 |
|||||||||||
Loans and borrowings |
8 |
|||||||||||
Deferred income tax liabilities |
||||||||||||
Total liabilities |
$ |
$ |
||||||||||
EQUITY (DEFICIT) |
||||||||||||
Share capital |
||||||||||||
Contributed surplus |
||||||||||||
Accumulative other comprehensive income |
||||||||||||
Deficit |
( |
) |
( |
) | ||||||||
Total shareholders’ equity (deficit) |
$ |
( |
) |
$ |
||||||||
Non-controlling interest |
||||||||||||
Total equity (deficit) |
$ |
( |
) |
$ |
||||||||
Total liabilities and equity |
$ |
$ |
“Russ McMeekin” |
“Michael Allman” |
||
Director |
Director |
1 | Condensed Consolidated Interim Financial Statements |
Three months ended March 31, |
||||||||||||
Notes |
2022 |
2021 |
||||||||||
Recast (Note 2) |
||||||||||||
Revenue | 4 | $ |
||||||||||
Cost of sales | ( |
) |
( |
) | ||||||||
Gross profit |
$ |
$ |
||||||||||
Expenses |
||||||||||||
Salaries, wages and benefits | ||||||||||||
Sales and marketing | ||||||||||||
Research and development | ||||||||||||
General and administration | ||||||||||||
Professional and consulting fees | ||||||||||||
Share-based compensation | 13 | |||||||||||
Depreciation and amortization | ||||||||||||
Total expenses |
$ |
$ |
||||||||||
Operating loss |
$ |
$ |
||||||||||
Other expenses (income) |
||||||||||||
Finance costs | 15(a) | $ |
$ |
|||||||||
Foreign exchange loss | ||||||||||||
Business acquisition costs and other expenses | — |
|||||||||||
Fair value (gain) loss on derivatives | 15(b) | ( |
) |
|||||||||
Other income | 15(c) | ( |
) |
( |
) | |||||||
Loss before tax |
$ |
$ |
||||||||||
Current tax expense | ||||||||||||
Deferred tax recovery | ( |
) |
( |
) | ||||||||
Net loss for the period |
$ |
$ |
||||||||||
Other comprehensive (income) loss Foreign subsidiary translation differences |
( |
) |
( |
) | ||||||||
Comprehensive loss for the period |
$ |
$ |
Net loss (income) for the period attributable to: |
||||||||
mCloud Technologies Corp. shareholders | $ | $ | ||||||
Non-controlling interest | ( |
) | ||||||
$ |
$ |
Comprehensive loss (income) for the period attributable to: |
||||||||
mCloud Technologies Corp. shareholders | $ | $ | ||||||
Non-controlling interest | ( |
) | ||||||
$ |
$ |
Loss per share attributable to mCloud shareholders - basic and diluted |
$ | $ | ||||||
Weighted average number of common shares outstanding - basic and diluted |
2 | Condensed Consolidated Interim Financial Statements |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income (loss) |
Deficit |
Total Shareholders’ Equity (Deficit) |
Non- controlling Interest |
Total Equity (Deficit) | ||||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||||||
Share-based payments |
13 |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||
RSUs exercised |
12(a) |
( |
) |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||
Warrants issued in financing |
12(b) |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||
Net loss for the period |
— |
— |
— |
— |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||
Other comprehensive income for the perio d |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Balance, March 31, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) | |||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||||||
Share-based payments |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||
RSUs exercised |
( |
) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||
Broker warrants issued |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||
Net (loss) income for the period |
— |
— |
— |
— |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Other comprehensive income for the period |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Balance, March 31, 2021 - Recast (Note 2) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
3 | Condensed Consolidated Interim Financial Statements |
Three months ended March 31, |
||||||||||||
Notes |
2022 |
2021 |
||||||||||
Operating activities |
Recast (Note 2) |
|||||||||||
Net loss for the period | $ | ( |
) | $ | ( |
) | ||||||
Items not affecting cash: | ||||||||||||
Depreciation and amortization | ||||||||||||
Share-based compensation | 13 | |||||||||||
Finance costs | 15(a) | |||||||||||
Fair value (gain) loss on derivatives | 15(b) | ( |
) | |||||||||
Other income | 15(c) | ( |
) | ( |
) | |||||||
Recovery of expected credit loss | ( |
) | — | |||||||||
Unrealized foreign currency exchange (gain) loss | ( |
) | ||||||||||
Current tax expense | ||||||||||||
Deferred income tax recovery | ( |
) | ( |
) | ||||||||
Increase (decrease) in working capital | 16(a) |
( |
) | |||||||||
Interest paid |
( |
) |
( |
) | ||||||||
Net cash used in operating activities |
$ |
( |
) |
$ |
( |
) | ||||||
Investing activities |
||||||||||||
Acquisition of property and equipment |
$ |
( |
) |
$ |
( |
) | ||||||
Expenditure on intangible assets |
— |
( |
) | |||||||||
Net cash used in investing activities |
$ |
( |
) |
$ |
( |
) | ||||||
Financing activities |
||||||||||||
Payment of lease liabilities |
$ |
( |
) |
$ |
( |
) | ||||||
Repayment of loans |
( |
) |
( |
) | ||||||||
Proceeds from loans and bank indebtedness, net of transaction costs |
||||||||||||
Net change in bank overdraft |
||||||||||||
Proceeds from issuance of convertible debentures, net of costs |
— |
|||||||||||
Net cash provided by financing activities |
$ |
$ |
||||||||||
Net decrease in cash and cash equivalents |
$ |
( |
) |
$ |
( |
) | ||||||
Effect of exchange rate fluctuations on cash held |
( |
) |
( |
) | ||||||||
Cash and cash equivalents, beginning of period |
||||||||||||
Cash and cash equivalents, end of period |
$ |
$ |
4 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
|
5 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
|
• |
the plan for the repayment of the 2019 Convertible Debentures; |
• |
• |
the likelihood that undrawn funds under the revolving operating facility will be available and will not be required to be repaid (Note 9); |
• |
the required cash principal and interest payments on indebtedness; |
• |
the likelihood of payments required under contingent consideration arrangements; |
• |
the available funding of US$ 8); |
• |
cash inflows from current operations, expected government assistance in the form of wage and rent subsidies, and expected increases in revenues and cash flows resulting from new revenue contracts expected over the next 12 months due to the anticipated reduction of COVID-19 related restrictions; and |
• |
future debt and equity raises. |
6 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
AssetCare initialization 1 |
$ | $ | ||||||
AssetCare over time 2 |
||||||||
Engineering services 3 |
||||||||
$ |
$ |
2 |
Revenues include sales of subscriptions to AssetCare, other subscriptions, post contract support and maintenance, perpetual software licenses, and installation and engineering services. |
3 |
Revenues includes consulting, implementation and integration services entered into on a time and materials basis or fixed fee basis without the use of AssetCare. |
Three months ended March 31, |
||||||||
Revenue recognized | 2022 |
2021 |
||||||
Over time | $ | $ | ||||||
At a point in time upon completion | ||||||||
$ |
$ |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Canada | $ | $ | ||||||
Americas | ||||||||
Asia Pacific | ||||||||
Other | ||||||||
Total revenue | $ |
$ |
7 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
Unbilled revenue |
Deferred revenue |
|||||||
Balance at December 31, 2021 | $ |
$ |
||||||
Additions | ||||||||
Less: transferred to trade and other receivables | ( |
) | — | |||||
Less: recognized in revenue | — | ( |
) | |||||
Effect of movements in exchange rates | — | |||||||
Balance at March 31, 2022 |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Trade receivables from contracts with customers | $ | $ | ||||||
Unbilled revenue (Note 4) | ||||||||
Indirect taxes receivable | ||||||||
Income taxes receivable | ||||||||
Other receivables | ||||||||
Contract asset | ||||||||
Loss allowance | ( |
) | ( |
) | ||||
Total trade and other receivables - current |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Current portion of long-term receivables 1 |
$ | $ | ||||||
Non-current portion of long-term receivables 2 |
||||||||
Total long-term receivables |
$ |
$ |
8 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
March 31, 2022 |
December 31, 2021 |
|||||||
Trade payables | $ | $ | ||||||
Accrued liabilities | ||||||||
Interest payable | ||||||||
Mastercard facility | ||||||||
Due to related parties | ||||||||
Income taxes payable | ||||||||
Indirect taxes payable | ||||||||
Other | ||||||||
Total trade payables and accrued liabilities |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Term loan (a) | $ | $ | ||||||
Nations Interbanc facility 2 |
||||||||
Debenture payable to Industry Canada | ||||||||
Loan payable to related party | ||||||||
Oracle financing | ||||||||
Other loans and financing | ||||||||
Total |
$ |
$ |
||||||
Current |
$ |
$ |
||||||
Non-current | $ | $ | ||||||
Total 1 |
$ |
$ |
1 |
Note 16(b) includes the reconciliation of liabilities to cash flows arising from financing activities. |
2 |
Nations advanced $ |
a) |
Term Loan |
9 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
b) |
Financing of Electric Vehicle Development Projects |
March 31, 2022 |
December 31, 2021 |
|||||||
ATB Financial revolving operating facility | $ | $ | ||||||
Bank overdraft | — | |||||||
Total |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Opening balance | $ | $ | ||||||
Interest paid | ( |
) | ( |
) | ||||
Accreted interest at effective interest rate | ||||||||
Carrying amount of liability component | $ | $ | ||||||
Less: interest payable | ( |
) | ( |
) | ||||
Total - current |
$ |
$ |
10 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
a) |
2019 Convertible debentures (continued) |
b) |
2021 Convertible debentures |
March 31, 2022 |
December 31, 2021 |
|||||||
2021 Convertible debenture liability | $ | $ | ||||||
2021 Convertible debenture embedded derivative | ||||||||
Total - non-current |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Derivative warrant liabilities - 2021 Debentures (a) | $ | $ | ||||||
Derivative warrant liabilities - USD equity financing (b) | ||||||||
Warrant liability related to business acquisition (c) | ||||||||
Other warrant liability (c) | — | |||||||
Total, all current |
$ |
$ |
a) |
Warrants associated with 2021 Debentures |
11 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
b) |
Warrants associated with USD equity financing |
c) |
Other warrant liabilities |
a) |
Common shares |
b) |
Warrants |
Number of Warrants |
Weighted Average Exercise Price | |||||||||
Balance, December 31, 2021 |
$ | |||||||||
Issued |
||||||||||
Balance, March 31, 2022 |
$ |
12 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Stock options (a) | $ | $ | ||||||
Restricted share units (b) | ||||||||
Total |
$ |
$ |
a) |
Stock Options |
Number of Options |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Life (years) | ||||||||||||
Outstanding, December 31, 2021 |
$ |
|||||||||||||
Granted |
$ | |||||||||||||
Forfeited |
( |
) | $ | |||||||||||
Expired |
( |
) | $ | |||||||||||
Outstanding, March 31, 2022 |
$ |
b) |
Restricted Share Units (“RSUs”) |
Number of RSUs |
||||||
Outstanding, December 31, 2021 |
||||||
Granted |
||||||
Exercised |
( |
) | ||||
Forfeited |
( |
) | ||||
Outstanding, March 31, 2022 |
||||||
Exercisable at March 31, 2022 |
13 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
a) |
Classification and measurement of financial assets and liabilities by category |
Financial assets |
Measurement basis |
March 31, 2022 |
December 31, 2021 |
|||||||
Cash and cash equivalents | Amortized cost | $ | $ | |||||||
Trade and other receivables 1 |
Amortized cost | |||||||||
Long-term receivables | Amortized cost | |||||||||
$ |
$ |
|||||||||
Financial liabilities |
||||||||||
Bank indebtedness | Amortized cost | $ | $ | |||||||
Trade payables and accrued liabilities 1 |
Amortized cost | |||||||||
Loans and borrowings | Amortized cost | |||||||||
Lease liabilities | Amortized cost | |||||||||
2019 Debentures - host liability | Amortized cost | |||||||||
2021 Debentures - host liability | Amortized cost | |||||||||
2021 Debentures embedded derivative | FVTPL | |||||||||
Warrant liability - business acquisition | FVTPL | |||||||||
Warrant liabilities - derivatives (Note 11) | FVTPL | |||||||||
Business acquisition payable | FVTPL | |||||||||
$ |
$ |
b) |
Measurement of fair value |
14 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
c) |
Financial instruments risk |
a) |
Finance Costs |
Three months ended March 31, | ||||||||
2022 |
2021 |
|||||||
Interest on loans and borrowings (Note 8) | $ | $ | ||||||
Interest on convertible debentures | ||||||||
Interest on lease liabilities | ||||||||
Transaction costs expensed | ||||||||
Other finance costs | ||||||||
Total finance costs |
$ |
$ |
b) |
Fair value gain (loss) on derivatives |
Three months ended March 31, | ||||||||
2022 |
2021 |
|||||||
Gain on warrant liability remeasurement (Note 11) 1 |
$ | ( |
) | $ | ||||
Gain on embedded derivatives 2 |
( |
) | ||||||
Deferred charge loss 2 |
||||||||
Total fair value (gain) loss on derivatives |
$ |
( |
) |
$ |
15 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
c) |
Other income |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Government assistance 1 |
$ | ( |
) | $ | ( |
) | ||
Government loan forgiveness | ( |
) | ||||||
Derecognition of contingent consideration | ( |
) | ||||||
Other | ( |
) | ( |
) | ||||
Total other income |
$ |
( |
) |
$ |
( |
) |
a) |
Changes in non-cash working capital |
For the three months ended March 31, |
2022 |
2021 |
||||||
Trade and other receivables decrease (increase) | $ | $ | ( |
) | ||||
Long-term receivables (increase) | ( |
) | ( |
) | ||||
Prepaid expenses and other assets decrease (increase) | ( |
) | ||||||
Trade payables and accrued liabilities increase | ||||||||
Deferred revenue increase | ||||||||
Increase (decrease) in working capital |
$ |
$ |
( |
) |
b) |
Changes in liabilities arising from financing activities |
For the three months ended March 31, |
2022 |
2021 |
||||||
Balance of loans, borrowings and PPP loans, beginning of period | $ | $ | ||||||
New advances | ||||||||
Repayments of principal | ( |
) | ( |
) | ||||
Repayments of interest | ( |
) | ( |
) | ||||
Liability related items |
||||||||
Finance fees paid | ||||||||
Non-cash related items |
||||||||
Accretion of interest and debt issuance costs | ||||||||
Benefit from below market interest rate | ( |
) | ||||||
Foreign exchange and other | ( |
) | ( |
) | ||||
Balance of loans, borrowings and PPP loans, end of period |
$ |
$ |
c) |
Non-cash investing and financing activities |
For the three months ended March 31, |
2022 |
2021 |
||||||
Non-cash accretion of interest included in finance costs 1 |
$ | $ | ||||||
Addition of right-of-use assets (Note 6) | $ | $ | ||||||
Addition to lease liabilities (Note 6) | $ | $ | ||||||
Non-cash broker warrants compensation | $ | $ |
1 |
Associated with convertible debentures. |
16 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
a) |
Loans and Borrowings - Change to Term Loan |
b) |
Loans and Borrowings - Additional funding under promissory note with Carbon |
17 | Condensed Consolidated Interim Financial Statements |
(i) | To include any prospectus required by section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) (§230.424(b) of this chapter) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement. |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (§230.424 of this chapter); |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
mCloud Technologies Corp. | ||
By: | /s/ Russell H. McMeekin | |
Name: | Russell H. McMeekin | |
Title: | Chief Executive Officer (Principal Executive Officer) | |
Dated: | August 9, 2022 |
Signature |
Title |
Date | ||
/s/ Russell H. McMeekin |
Chief Executive Officer |
August 9, 2022 | ||
Russell H. McMeekin |
(Principal Executive Officer) |
|||
/s/ Chantal Schutz |
Chief Financial Officer |
August 9, 2022 | ||
Chantal Schutz |
(Principal Accounting and Financial Officer) |
|||
/s/ * |
Director |
August 9, 2022 | ||
Michael Allman |
||||
/s/ * |
Director |
August 9, 2022 | ||
Constantino Lanza |
||||
/s/ * |
Director |
August 9, 2022 | ||
Elizabeth MacLean |
||||
/s/ * |
Director |
August 9, 2022 | ||
Ian C. W. Russell |
*By: |
/s/ Russell H. McMeekin |
Attorney-in-fact |
August 9, 2022 | |||
Russell H. McMeekin |
Authorized U.S. Representative | ||
By: |
/s/ Russell H. McMeekin | |
Name: Russell H. McMeekin | ||
Title: Chief Executive Officer |